Advertisement

Allergic Diseases (and Differential Diagnoses)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bachert C, Hauser U, Prem B, Rudack C, Ganzer U (1995) Proinflammatory cytokines in allergic rhinitis. Eur Arch Otorhinolaryngol 1[Suppl]:44–49CrossRefGoogle Scholar
  2. 2.
    Bachmann W, Bachert C (1984) Quantitative evaluation of rhinomanometric curves. A new simple method. Laryngol Rhinol Otol 63:58–61CrossRefGoogle Scholar
  3. 3.
    Bousquet J, Vignola AM, Campbell AM, Michel FB (1996) Pathophysiology of allergic rhinitis. Int Arch Allergy Immunol 110:207–218PubMedCrossRefGoogle Scholar
  4. 4.
    Busse WW, Holgate ST (eds) (1995) Asthma and rhinitis. Blackwell, OxfordGoogle Scholar
  5. 5.
    Canonica GW, Ciprandi G, Pesce GP, Buscaglia S, Paolieri F, Bagnasco M (1995) ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. Int Arch Allergy Immunol 107: 99–102PubMedCrossRefGoogle Scholar
  6. 6.
    Durham SR (1998) Mechanisms of mucosal inflammation in the nose and lungs. Clin Exp Allergy 28[Suppl 2]:15–16Google Scholar
  7. 7.
    Ellegard E, Karlsson G (1999) Nasal congestion during pregnancy. Clin Otolaryngol 24:307–311PubMedCrossRefGoogle Scholar
  8. 8.
    Heppt W (1998) Zytologie der Nasenschleimhaut. Springer, Berlin Heidelberg New YorkGoogle Scholar
  9. 9.
    Malm L, van-Wijk RG, Bachert C (1999) Guidelines for nasal provocations with aspects on nasal patency, airflow, and airflow resistance. Rhinology 37:133–135Google Scholar
  10. 10.
    Mygind N, Dahl R, Pedersen S, Thestrup-Pedersen K (1996) Essential Allergy. Blackwell Science, OxfordGoogle Scholar
  11. 11.
    Mygind N, Laussen LC, Dahl M (2000) Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy. Allergy 55:11–15PubMedCrossRefGoogle Scholar
  12. 12.
    Naclerio RM (1997) Pathophysiology of perennial allergic rhinitis. Allergy 52:41–44CrossRefGoogle Scholar
  13. 13.
    Nolte D, Renovanz HD, Schumann K (1982) Nase und Respirationstrakt. Obere und untere Luftwege als funktionelle Einheit. Dustri, MunichGoogle Scholar
  14. 14.
    Passalacqua G, Bachert C, Davies RJ, Durham SR, et al. (2000) Inhaled and nasal corticosteroids: safety aspects. Position paper. Allergy 55:16–33PubMedCrossRefGoogle Scholar
  15. 15.
    Simons FE (1996) Learning impairment and allergic rhinitis. Allergy Asthma Proc 17:185–189PubMedCrossRefGoogle Scholar
  16. 16.
    Simons FE (1999) Allergic rhinobronchitis: The asthma-allergic rhinitis link. J Allergy Clin Immunol 104:534–540PubMedCrossRefGoogle Scholar
  17. 17.
    van Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, Canonica GW, Durham SR, Fokkens WJ, Howarth PH, Lund V, Malling HJ, Mygind N, Passali D, Scadding GK, Wang DY (2000) Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 55:116–134PubMedCrossRefGoogle Scholar
  18. 18.
    Tas E, Bircher AJ (2001) Therapie der Rhinitis allergica. Ther Umsch 58:309–314PubMedCrossRefGoogle Scholar
  19. 19.
    van Wijk RG, de Graaf-in’ t Veld C, Garrelds IM (1999) Nasal hyperreactivity. Rhinology 37:50–55Google Scholar
  20. 20.
    World Health Organization (2004) Allergic rhinitis and its impact on asthma (ARIA). In: Bousquet J, et al. (eds) Executive summary. WHO (in press)Google Scholar
  21. 21.
    Wüthrich B, Schindler C, Leuenberger P, Ackermann-Liebrich U (1995) Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Diseases in Adults. Int Arch Allergy Immunol 106:149–156PubMedCrossRefGoogle Scholar

References

  1. 1.
    National Institutes of Health (1997) Expert Panel Report 2: Guidelines for the diagnosis and management of asthma. Publication 97-4051, NIH, BethesdaGoogle Scholar
  2. 2.
    American Thoracic Society (2000) Guidelines for methacholine challenge and exercise challenge testing. Am J Respir Crit Care Med (2000) 161: 309–329Google Scholar
  3. 3.
    Bachert C (1997) Asthma and rhinitis: management implications. Eur Respir J 7:294–295Google Scholar
  4. 4.
    Barnes PJ, Chung F, Page CP (1998) Inflammatory mediators of asthma. An update. Pharmacol Rev 50:515–596PubMedGoogle Scholar
  5. 5.
    Baur X (1986) Asthma, alveolitis, aspergillose. Charakterisierung ursächlicher Allergene. Springer, Berlin Heidelberg New YorkGoogle Scholar
  6. 6.
    Bernstein DJ (1997) Allergic reactions to workplace allergens. JAMA 278:1907–1913PubMedCrossRefGoogle Scholar
  7. 7.
    Borelli S, Düngemann H (eds) (1981) Fortschritte der Allergologie und Dermatologie. IMP-Verlag, BaselGoogle Scholar
  8. 8.
    Busse WW, Elias J, Sheppard D, et al. (1999) Airway remodeling and repair. Am J Respir Crit Care Med 160:1035–1042PubMedGoogle Scholar
  9. 9.
    Crapo RO (1994) Pulmonary function testing. N Engl J Med 331:25–30PubMedCrossRefGoogle Scholar
  10. 10.
    Debelic M (ed) (1986) Bronchitis im Kindes-und Jugendlichenalter. Dustri, MunichGoogle Scholar
  11. 11.
    Doerschug KC, Peterson MW, Dayton CS, et al. (1999) Asthma guidelines. An assessment of physician understanding and practice. Am J Respir Crit Care Med 159:1735–1741PubMedGoogle Scholar
  12. 12.
    Düngemann H (1978) Karenz-Expositionsprophylaxe. Atemwegs Lungenkrankh 4Google Scholar
  13. 13.
    Dykewicz MS, Fineman S (eds) (1998) Diagnosis and management of rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 81:478–518Google Scholar
  14. 14.
    Fischer A, McGregor GP, Saria A, Philipp B, Kummer W (1996) Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. J Clin Invest 98:2284–2291PubMedCrossRefGoogle Scholar
  15. 15.
    Fruhmann G (1994) Sonstige Berufskrankheiten: Obstruktive Atemwegserkrankungen. In: Ferlinz R (ed) Pneumologie. Thieme, Stuttgart, p 622ffGoogle Scholar
  16. 16.
    Fuchs E (1982) Gewerbliche Allergene als Ursache obstruktiver Lungenerkrankungen. Früherkennung und Abklärung. Schweiz Med Wochenschr 112:185PubMedGoogle Scholar
  17. 17.
    Fuchs E, Schultze-Werninghaus G (1986) Asthma bronchiale. Themen der Medizin 7. Wander, NürnbergGoogle Scholar
  18. 18.
    Gonsior E, Henzgen M, Jörres RF, Kroidl RF, Merget R, Riffelmann FW, Wallenstein GW (2001) Leitlinie für die Durchführung bronchialer Provokationstests mit Allergenen. Deutsche Ges für Allergologie und klinische Immunologie. Allergo J 10: 193–199, 257–264Google Scholar
  19. 19.
    Hansen K (1957) Bronchialasthma (Bronchiolenasthma) und verwandte Störungen. In: Hansen K (ed) Allergie. Thieme, StuttgartGoogle Scholar
  20. 20.
    Hansel TT, Bauer PJ (eds) (2001) New drugs for asthma, allergy and COPD. Progress in respiration research, vol 31. Karger, BaselGoogle Scholar
  21. 21.
    Henderson WR, Shelhamer JH, Reingold DB, Smith LJ, Evans R, Kaliner M (1979) Alpha-adrenergic hyper-responsiveness in asthma. N Engl J Med 300:642–647PubMedGoogle Scholar
  22. 22.
    Holgate ST, Davies DE, Lackie PM, Wilson SY, Puddicombe SL, Lordan JL (2000) Epitheliolmesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 105:193–204PubMedCrossRefGoogle Scholar
  23. 23.
    Kay AB, Austen KF, Lichtenstein LM (eds) (1984) Asthma. Physiology, immunopharmacology and treatment. Academic Press, LondonGoogle Scholar
  24. 24.
    Kerschensteiner M, Gallmeier E, Behrens L, Vargas Leal V, Misgeld T, Klinkert WEF, Kohlbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R (1999) Activated human T cells, B cells, and monocytes produce brain-derived neutrophic factor in vitro and in inflammatory brain lesions: A neutroprotective role of inflammation? J Exp Med 189:865–870PubMedCrossRefGoogle Scholar
  25. 25.
    Kjellmann N-IM (1976) Immunoglobulin E and atopic allergy in childhood. Linköping University Medicine Dissertation No. 36Google Scholar
  26. 26.
    König P (1985) Therapie des Status asthmaticus. Internist 26:208PubMedGoogle Scholar
  27. 27.
    Kunkel G (2001) Neurogene Aspekte der allergischen Entzündungsreaktion. In: Ring J, Darsow V (eds) Allergie 2000: Probleme, Strategien und praktische Konsequenzen. Dustri, Munich, pp 179–181Google Scholar
  28. 28.
    Kroegel C (ed) (1997) Moderne Therapie des Asthma bronchiale. Thieme, StuttgartGoogle Scholar
  29. 29.
    Lebowitz MD, Barbee R, Burrows B (1984) Family concordance of IgE, atopy, and disease. J Allergy Clin Immunol 73:259–264PubMedCrossRefGoogle Scholar
  30. 30.
    Magnussen H (1990) Überempfindlichkeit der Atemwege. Dtsch med Wochenschr 115:1604–1610PubMedCrossRefGoogle Scholar
  31. 31.
    Middleton E Jr et al. (eds) (1998) Allergy: principles and practice, 5th edn. Mosby, St. Louis, pp 544–558Google Scholar
  32. 32.
    Milgrom H, Fick RB, Su JQ, et al. (1999) Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med 341:1966–1973PubMedCrossRefGoogle Scholar
  33. 33.
    Nadel JA (ed) (1980) Physiology and pharmacology of the airways. Marcel Dekker, New YorkGoogle Scholar
  34. 34.
    Niggemann B, Illi S, Madloch C (2001) Histamine challenges discriminate between symptomatic and asymptomatic children. MAS study group. Eur Resp J 17:246–253CrossRefGoogle Scholar
  35. 35.
    Nolte D (1996) Asthma: Das Krankheitsbild, der Asthmapatient, die Therapie, 6th edn. Urban & Schwarzenberg, MunichGoogle Scholar
  36. 36.
    Reinhardt D (ed) (1996) Asthma bronchiale im Kindesalter. Springer, Berlin Heidelberg New YorkGoogle Scholar
  37. 37.
    Schultze-Werninghaus G (ed) (1999) Deutsche Atemwegsliga: Empfehlungen zur Allergiediagnostik bei Atemwegserkrankungen in der Praxis. Pneumologie 48:300–304Google Scholar
  38. 38.
    Schultze-Werninghaus G (1997) Die Immuntherapie (allergenspezifische Hyposensibilisierung) bei Asthma bronchiale. Atemw Lungenkrh 23: 701–707Google Scholar
  39. 39.
    Slavin RG, Reisman RE (eds) Expert guide to allergy and immunology. American College of Physicians, Philadelphia, pp 23–40Google Scholar
  40. 40.
    Szepanski R, Lecheler J (1995) Standard-und Qualitätssicherung der Asthmaschulung im Kindes-und Jugendalter. Präv Rehab 7:1–41Google Scholar
  41. 41.
    Tiffeneau R, Beauvallet M (1945) Production exclusive d’effets pulmonaires locaux par inhalation d’aerosol d’acetylcholine. Son utilisation comme test d’insufficance respiratoire. Sem Hop (Paris) 21:154–166Google Scholar
  42. 42.
    Townsley RG (1976) IgE levels and methacholine inhalation responses in monozygous and dizygous twins. J Allergy Clin Immunol 57:227Google Scholar
  43. 43.
    Virchow JC, Kroegel C, Walker C, Matthyss H (1994) Cellular and immunological markers of allergic and intrinsic bronchial asthma. Lung 172:313–334PubMedCrossRefGoogle Scholar
  44. 44.
    Virchow JC, Prasse A, Naya I, Summertin A, Harris A (2000) Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med 62:578–585Google Scholar
  45. 45.
    Wahn U, Seger S, Wahn V (eds) (1999) Pädiatrische Allergologie und Immunologie, 3rd edn. Urban und Fischer, MunichGoogle Scholar
  46. 46.
    Wettengel R, Berdel D, Cegla U, et al. (1994) Empfehlungen der Deutschen Atemwegsliga zum Asthmamanagement bei Erwachsenen und Kindern. Med Klin 89:57–67Google Scholar
  47. 47.
    Worth H, Meyer A, Folgering H, Kirsten D, Lecheler J, Magnussen H, Pleyer K, Schmidt S, Schmitz M, Taube K, Wettengel R (2000) Empfehlungen der Deutschen Atemwegsliga zum Sport und körperlichen Training bei Patienten mit obstruktiven Atemwegserkrankungen. Pneumologie 54: 61–67PubMedCrossRefGoogle Scholar
  48. 48.
    Wüthrich B (1976) Zum Allergenkatalog beruflicher Inhalationsallergien. Berufsdermatosen 24:123Google Scholar

References

  1. 1.
    Abeck D, Thomsen S, Plötz S, Ring J (1999) Die Biologische Urtikaria-Therapie. Acta Biol 38:3–23Google Scholar
  2. 2.
    Beissert S, Stauder H, Schwarz T (2000) UVA rush hardening for the treatment of solar urticaria. J Am Acad Dermatol 42:1030–1032PubMedCrossRefGoogle Scholar
  3. 3.
    Bork K, Witzke G (1989) Long-term prophylaxis with C1-inhibitor (C1INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency. J Allergy Clin Immunol 83:677PubMedCrossRefGoogle Scholar
  4. 4.
    Braun-Falco O (1976) Entwicklungen in der Dermatologie. In: Braun-Falco O, Marghescu S (eds) Fortschritte der praktischen Dermatologie und Venerologie, vol 8. Springer, Berlin Heidelberg New York, p 417Google Scholar
  5. 5.
    Champion RH (1988) Urticaria then and now. Br J Dermatol 119:427–436PubMedCrossRefGoogle Scholar
  6. 6.
    Doeglas HMG (1975) Reactions to aspirin and food additives in patients with chronic urticaria, including the physical urticarias. Br J Dermatol 93:135PubMedCrossRefGoogle Scholar
  7. 7.
    Ellis MH (1998) Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol 102:876–877PubMedCrossRefGoogle Scholar
  8. 8.
    Fiebiger E, Hammerschmid F, Stingl G, Maurer D (1998) Anti-FcεRIα autoantibodies in autoimmune-mediated disorders. J Clin Invest 101:243–251PubMedCrossRefGoogle Scholar
  9. 9.
    Greaves M (2000) Chronic urticaria. J Allergy Clin Immunol 105:664–671PubMedCrossRefGoogle Scholar
  10. 10.
    Haas N, et al. (1995) Vergleichende Studie zur Häufigkeit, Diagnostik und Therapie der Urtikaria in einer Hautpoliklinik. Allergologie 18:110–113Google Scholar
  11. 11.
    Henz BM (1996) Das Spektrum der Urtikaria. In: Henz BM, Zuberbier T, Grabbe J (eds) Urtikaria. Klinik, Diagnostik, Therapie. Springer, Berlin Heidelberg New York, pp 1–17Google Scholar
  12. 12.
    Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW (1993) Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 328:1599–1604PubMedCrossRefGoogle Scholar
  13. 13.
    Illig L, Paul E (1978) Die Stellung der Antihistaminika in der Urtikaria-Therapie. Hautarzt 29:407PubMedGoogle Scholar
  14. 14.
    Juhlin L (1981) Modem approaches to treatment of chronic urticaria. In: Ring J, Burg G (eds) New trends in allergy. Springer, Berlin Heidelberg New York, p 279Google Scholar
  15. 15.
    Kaplan AP (1981) The pathogenic basic of urticaria and angioedema: Recent advances. Am J Med 70:755–757PubMedCrossRefGoogle Scholar
  16. 16.
    Kumar SA, Martin BL (1999) Urticaria and angioedema: diagnostic and treatment considerations. J Am Osteopath Assoc 99[Suppl]:1–4Google Scholar
  17. 17.
    Leznoff A, Sussmann GL (1989) Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: A study of 90 patients. J Allergy Clin Immunol 84:66PubMedCrossRefGoogle Scholar
  18. 18.
    Leznoff A (1998) Chronic urticaria. Can Fam Physician 44:2170–2176PubMedGoogle Scholar
  19. 19.
    Maibach HI, Johnson HL (1975) Contact urticaria syndrome. Contact urticaria to diethyltoluamide. Arch Dermatol 111:720–730CrossRefGoogle Scholar
  20. 20.
    Merk H (1992) Urticaria und Rhinitis allergica: In: Hornbostel H, Kaufmann W, Siegenthaler W (eds) Innere Medizin in Praxis und Klinik, 4th edn. Thieme, Stuttgart, pp 3281–3293Google Scholar
  21. 21.
    Meurer M (1981) Urticaria vasculitis. In: Ring J, Burg G (eds) New trends in allergy. Springer, Berlin Heidelberg New York, pp 148–151Google Scholar
  22. 22.
    Müller J, Vieluf D, Ring J (1993) Schilddrüsenhormone als Amplifikatoren der Histamin-Freisetzung unter Insektengift-Hyposensibilisierung. Allergo J 2[Suppl 2]:77–8Google Scholar
  23. 23.
    Ollert M, Ring J (2000) Urtikaria und Angioödem. In: Przybilla B, Bergmann K, Ring J (eds) Praktische allergologische Diagnostik. Stein-kopff, Darmstadt, pp 328–334Google Scholar
  24. 24.
    Opferkuch W, Kövary PM, Jaeger U, Echternacht-Happle K, Gronemeyer W, Hammar C, Niemczyk H, Rieger C (1981) Clinical aspects and therapy of hereditary angioneurotic edema. In: Ring J, Burg G (eds) New trends in Allergy. Springer, Berlin Heidelberg New York, p 272Google Scholar
  25. 25.
    Paul E, Bödeker R-H (1987) Behandlung der chronischen Urticaria mit Terfenadin und Ranitidin. Allergologie 10:113Google Scholar
  26. 26.
    Ring J, Brockow K, Ollert M, Engst R (1999) Antihistamines in urticaria. Clin Exp Allergy 29[Suppl 1]:31–37PubMedCrossRefGoogle Scholar
  27. 27.
    Ring J, Przybilla B (1987) Diagnostik der chronischen Urtikaria. Med Welt 38:256–259Google Scholar
  28. 28.
    Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW (1999) The autologous serum skin test: A screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 140:446–452PubMedCrossRefGoogle Scholar
  29. 29.
    Schäfer T, Ring J (1996) Epidemiology adverse food reactions due to allergy and other forms of hypersensitivity. In: Eisenbrand G et al. (eds) Food allergies and intolerances. DFG, VCH Weinheim, pp 40–54Google Scholar
  30. 30.
    Schmutzler W (1997) Histamin als Mediator allergischer Reaktionen. Allergologie 20:536–542Google Scholar
  31. 31.
    Skrebova N, Takiwaki H, Miyaoka Y, Arase S (2001) Localized heat urticaria: a clinical study using laser Doppler flowmetry. J Dermatol Sci 26:112–118PubMedCrossRefGoogle Scholar
  32. 32.
    Schrallhammer-Baenkler S, Ring J, Landthaler M (1985) Localized heat urticaria. Arch Dermatol Res 277:406CrossRefGoogle Scholar
  33. 33.
    Toubi E, Blant A, Kessel A, Golan TD (1997) Low dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy 52:312–316PubMedCrossRefGoogle Scholar
  34. 34.
    Warin RP, Champion RH (1974) Urticaria. Saunders, LondonGoogle Scholar
  35. 35.
    Wüthrich B (1989) Therapie der akuten und chronischen Urtikaria und des Quincke-Ödems. Schweiz Rundschau Med 78:576–581Google Scholar
  36. 36.
    Zuberbier T, Henz BM (1996) Diagnostik der Urtikaria. In: Henz BM, Zuberbier T, Grabbe J (eds) Urtikaria. Klinik, Diagnostik, Therapie. Springer, Berlin Heidelberg New York, pp 137–156Google Scholar
  37. 37.
    Zuberbier T, Aberer W, Grabbe J, Hartmann K, Merk H, Ollert M, Rueff F, Wedi B, Wenning J (2004) Diagnostik und Therapie der Urtikaria. Leitlinie der DDG und DGAI. Allergo J (in press)Google Scholar

References

  1. 1.
    Barnard JH (1973) Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol 52:259–264PubMedCrossRefGoogle Scholar
  2. 2.
    Bochner BS, Lichtenstein LM (1991) Anaphylaxis. N Engl J Med 324:81–88Google Scholar
  3. 3.
    Brockow K, Kiehn M, Riehtmüller C, Vieluf D, Berger J, Ring J (1997) Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera venom immunotherapy: a prospective randomized placebo-controlled trial. J Allergy Clin Immunol 100:458–463PubMedCrossRefGoogle Scholar
  4. 4.
    Brown MJ, Brown DC, Murphy MB (1983) Hypokalemia from beta-2-receptor stimulation by circulating epinephrine. N Engl J Med 309: 1414–1419PubMedCrossRefGoogle Scholar
  5. 5.
    Capurro N, Levi R (1975) The heart as target organ in systemic allergic reactions. Circ Res 36:520–528PubMedGoogle Scholar
  6. 6.
    Delage C, Irey HC (1972) Anaphylactic deaths: a clinicopathologic study of 43 cases. J Forens Sci 17:525Google Scholar
  7. 7.
    De Soto H, Turk P (1989) Cimetidine in anaphylactic shock refractory to standard therapy. Anesth Analg 69:264–265PubMedCrossRefGoogle Scholar
  8. 8.
    Eisenberg MS, Mengest TJ (2001) Cardiac resuscitation. N Engl J Med 344:1304–1313PubMedCrossRefGoogle Scholar
  9. 9.
    Endrich B, Ring J, Intaglietta M (1979) Effects of radiopaque contrast media on the microcirculation of the rabbit omentum. Radiology 132: 331–339PubMedGoogle Scholar
  10. 10.
    Fisher MMD (1986) Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anesth Intensive Care 17:17–21Google Scholar
  11. 11.
    Fuchs E, Ferlinz R (1986) Allergische Krankheiten. In: Wolff HR v, Weihrauch TR (eds) Internistische Therapie, 6th edn. Urban und Schwarzenberg, Munich, pp 275–288Google Scholar
  12. 12.
    Gronemeyer W (1980) Noradrenalin statt Adrenalin beim anaphylaktischen Schock. Dtsch Med Wochenschr 102:101Google Scholar
  13. 13.
    Hannaway PJ, Hoppler GDK (1983) Severe anaphylaxis and drug induced beta-blockage. N Engl J Med 308:1536PubMedGoogle Scholar
  14. 14.
    Hermann K, Ring J (1997) The renin-angiotensin system in patients with repeated anaphylactic reactions during Hymenoptera venom hyposensitization and sting challenge. Int Arch Allergy Immunol 11:251–156CrossRefGoogle Scholar
  15. 15.
    Johansson SGO, Hourihane JOB, Bousquet J, Bruijnzeel-Koomen, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hage-Hamsten M, Wüthrich B (2001) A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 56:813–824PubMedCrossRefGoogle Scholar
  16. 16.
    Kleinhans D (1987) Anstrengungs-induzierte Urtikaria und Anaphylaxie. Med Klein 82:103–104Google Scholar
  17. 17.
    Laubenthal H (1986) Dextrananaphylaxie, Pathomechanismus und Prophylaxe. Ergebnisse einer multizentrischen Studie. Springer, Berlin Heidelberg New YorkGoogle Scholar
  18. 18.
    Lockey RF, Benedict LM, Turkeltaub TB, Bukantz SC (1987) Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 79:666–677CrossRefGoogle Scholar
  19. 19.
    Lorenz W, Doenicke A, Dittmann I, Hug P, Schwarz B (1977) Anaphylaktoide Reaktionen nach Applikation von Blutersatzmitteln beim Menschen. Verhinderung dieser Nebenwirkung von Haemaccel durch Praemedikation mit H1 und H2-Antagonisten. Anaesthesist 26:644PubMedGoogle Scholar
  20. 20.
    Marone G, Patelle V, Crescanzo A de, Genovese M (1995) Human heart mast cells in anaphylaxis and cardiovascular disease. Int Arch Allergy Immunol 107:72–75PubMedCrossRefGoogle Scholar
  21. 21.
    Maulitz RM, Pratt DS, Schocket AL (1979) Exercise-induced anaphylactic reaction to shellfish. J Allergy Clin Immunol 63:433PubMedCrossRefGoogle Scholar
  22. 22.
    Meßmer K (1983) Plasma substitutes and indications for their use. In: Tinker J, Rapin M (eds) Care of the critically ill patient. Springer, Berlin Heidelberg New York, pp 569–575Google Scholar
  23. 23.
    Müller U (2001) Spätkomplikationen bei Anaphylaxie. In: Ring J, Darsow U (eds) “Allergie 2000: Probleme, Strategien und praktische Kon-sequenzen”. Dustri, Munich, pp 249–252Google Scholar
  24. 24.
    Pavek K, Wegmann A, Nordström L, Schwander D (1982) Cardiovascular and respiratory mechanisms in anaphylactic and anaphylactoid shock reactions. Klin Wochenschr 60:941–947PubMedCrossRefGoogle Scholar
  25. 25.
    Przybilla B, Ring J (1983) Anaphylaxis to ethanol and sensitization to acetic acid. Lancet 1:483PubMedCrossRefGoogle Scholar
  26. 26.
    Pumphrey RS (2000) Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 30:1144–1150PubMedCrossRefGoogle Scholar
  27. 27.
    Reimers A, Müller U (2000) Behandlung des anaphylaktischen Schocks. Ther Umschau 58:325–328CrossRefGoogle Scholar
  28. 28.
    Richet C (1904) De l’anaphylaxie ou sensibilite croissante des organismes a des doses successives de poison. Arch Fisiol 1:129Google Scholar
  29. 29.
    Richter W, Hedin H, Ring J, Kraft D, Messmer K (1980) Anaphylaktoide Reaktionen nach Dextran I. Immunologische Grundlagen und klinische Befunde. Allergologie 3:9Google Scholar
  30. 30.
    Ring J, Messmer K (1977) Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1:466–468PubMedCrossRefGoogle Scholar
  31. 31.
    Ring J (1978) Anaphylaktoide Reaktionen nach Infusion naturlicher und künstlicher Kolloide. Springer, Berlin Heidelberg New YorkGoogle Scholar
  32. 32.
    Ring J, Darsow U (2002) Idiopathic anaphylaxis. Curr Allergy Asthma Rep 2:40–45PubMedCrossRefGoogle Scholar
  33. 33.
    Ring J, Galosi A, Przybilla B (1986) Contact anaphylaxis from emulgade F. Contact Dermatitis 15:49–40CrossRefGoogle Scholar
  34. 34.
    Ring J, Behrendt H (1999) Anaphylaxis and anaphylactoid reactions. Classification and pathophysiology. Clin Rev Allergy Immunol 17:387–399PubMedCrossRefGoogle Scholar
  35. 35.
    Rohrer CL, Pichler WJ, Helbling A, et al. (1998) Anaphylaxie: Klinik, Ätiologie und Verlauf bei 118 Patienten. Schweiz Med Wochenschr 128: 53–63PubMedGoogle Scholar
  36. 36.
    Sheffer AL, Austen KF (1980) Exercise-induced anaphylaxis. J Allergy Clin Immunol 66:106PubMedCrossRefGoogle Scholar
  37. 37.
    Simons FE, Gu X, Johnston LM, Simons KJ (2000) Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis? Pediatrics 106:1040–1044PubMedCrossRefGoogle Scholar
  38. 38.
    Smedegard G, Revenäs B, Arfors KE (1979) Anaphylaxis in the monkey: hemodynamics and blood flow distribution. Acta Physiol Scand 106:191PubMedCrossRefGoogle Scholar
  39. 39.
    Smith PL, Kagey-Sobotka A, Blecker ER, Traystman R, Kaplan AP, Gralink H, Valentine MD, Permut S, Lichtenstein LM (1980) Physiologic manifestations of human anaphylaxis. J Clin Invest 60:1072CrossRefGoogle Scholar
  40. 40.
    Sullivan TJ (1982) Cardiac disorders in penicillin-induced anaphylaxis: association with intravenous epinephrine therapy. J Am Med Assoc 248:2161CrossRefGoogle Scholar
  41. 41.
    Stark BJ, Sullivan TJ (1986) Biphasic and protracted anaphylaxis. J Allergy Clin Immunol 78:76–83PubMedCrossRefGoogle Scholar
  42. 42.
    Tryba M, Ahnefeld FW, Barth J, Dick W, Doenicke A, Fuchs T, Gervais H, Laubenthal H, Löllgen H, Lorenz W, Mehrkens HH, Meuret GH, Möllmann H, Piepenbrock S, Przybilla B, Ring J, Schmutzler W, Schultze-Werninghaus G, Schüttler J, Schuster JP, Sefrin P, Zander J, Zenz M (1994) Akuttherapie anaphylaktoider Reaktionen. Ergebnisse einer interdisziplinären Konsensuskonferenz. Allergo J 3:211–222Google Scholar
  43. 43.
    Waldhausen E, Keser G, Marquardt B (1987) Der anaphylaktische Schock. Anästhesist 36:150–158Google Scholar
  44. 44.
    Wegmann A, Reuker H, Pavek K, Schwander D (1983) Katecholamintherapie und Herzrhyth-musstörungen im anaphylaktischen und anaphylaktoiden Schock. Anaesthesist 32[Suppl]:320Google Scholar
  45. 45.
    Wiggins CA, Dykowicz MS, Patterson R (1988) Idiopathic anaphylaxis. Classification, evaluation and treatment of 123 patients. J Allergy Clin Immunol 82:849–855PubMedCrossRefGoogle Scholar
  46. 46.
    Zaloga GP, Delacey W, Holmboe E, Chernow B (1986) Glucagon reversal of hypotension in a case of anaphylactoid shock. Ann Intern Med 105:65–66PubMedGoogle Scholar

References

  1. 1.
    Aas K (1978) The diagnosis of hypersensitivity to ingested foods. Reliability of skin prick testing and the radioallergosorbent test with different materials. Clin Allergy 8:39–50PubMedCrossRefGoogle Scholar
  2. 2.
    Andrée C (1984) L’allergie digestive, concept ou realité? Presse Med 27:1667–1669Google Scholar
  3. 3.
    Bauer CP Grübl A (2002) Hypoallergene Babynahrung. In: Behr-Völtzer C, Hamm M, Vieluf D, Ring J (eds) Diät bei Nahrungsmittelallergien und-intoleranzen, 2nd edn. Urban & Vogel, Munich, pp 105–111Google Scholar
  4. 4.
    Ballmer-Weber BK, Wüthrich B (2001) Die Nahrungsmittelallergie und ihre diätetische Behandlung. Aktuell Ernähr Med 26:196–201CrossRefGoogle Scholar
  5. 5.
    Behr-Völtzer C, Hamm M, Vieluf D, Ring J (eds) (2002) Diät bei Nahrungsmittelallergien und-intoleranzen, 2nd edn. Urban & Vogel, MunichGoogle Scholar
  6. 6.
    Balmer-Weber B, Bengtsson U, et al. (2004) Standardization of food challenges in patients with immediate reactions to foods. Position paper EAACI. Allergy (in press)Google Scholar
  7. 7.
    Bischoff SC, Mayer J, Wedemeyer J, et al. (1997) Colonoscopic allergen provocation (CO-LAP): a new diagnostic approach for gastrointestinal food allergy. Gut 40:745–753PubMedCrossRefGoogle Scholar
  8. 8.
    Bock SA, Sampson HA, Atkins FM, Zeiger RS, et al. (1988) Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. J Allergy Clin Immunol 82:986–997PubMedCrossRefGoogle Scholar
  9. 9.
    Brostoff J, Challacombe SJ (eds) (1987) Food allergy and intolerance. Bailliere Tindall, LondonGoogle Scholar
  10. 10.
    Bruijnzeel-Koomen C, Ortolani C, Aas K, et al. (1995) Adverse reactions to food. European Academy of Allergology and Clinical Immunology Subcommittee. Allergy 50:623–635PubMedCrossRefGoogle Scholar
  11. 11.
    Deutsche Gesellschaft für Ernährung (ed) (1995) Richtig essen. F+G Rollendruck, BerlinGoogle Scholar
  12. 12.
    Diätverband — Bundesverband der Hersteller von Lebensmitteln für besondere Ernährungszwecke (ed) (1998) Product & Diät. Presto, HemmingenGoogle Scholar
  13. 13.
    Ebner C, Hirschwehr R, Bauer L, et al. (1995) Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin). J Allergy Clin Immunol 95:962–969PubMedCrossRefGoogle Scholar
  14. 14.
    Egger J, Carter CM, Wilson J, Turner MW, Soot-hill JF (1983) Is migraine food allergy? A double blind controlled trial of oligoantigenic diet treatment. Lancet 2:865–869PubMedCrossRefGoogle Scholar
  15. 15.
    Ehlers I, Henz B, Zuberbier T (1996) Diagnose und Therapie pseudo-allergischer Reaktionen der Haut durch Nahrungsmittel. Allergologie 19: 270–276Google Scholar
  16. 16.
    Eisenbrand G, Aulepp H, Dayan AD, et al. (1996) Food allergies and intolerances. VCH Verlagsge-sellschaft, WeinheimGoogle Scholar
  17. 17.
    Eisenmann A, Ring J, Helm D von der, Meurer M, Braun-Falco O (1988) Vasculitis allergica durch Nahrungsmittelallergie. Hautarzt 39:318–321PubMedGoogle Scholar
  18. 18.
    Ewan PW, Clark AT (2001) Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan. Lancet 357:111–115PubMedCrossRefGoogle Scholar
  19. 19.
    Feingold B (1975) Why your child is hyperactive. Random, New YorkGoogle Scholar
  20. 20.
    Franck P, Moneret Vautrin DA, Dousset B, et al. (2002) The allergenicity of soybean-based products is modified by food technologies. Int Arch Allergy Immunol 128:212–219PubMedCrossRefGoogle Scholar
  21. 21.
    Häberle M (1987) Klinische und lebensmittelchemische Aspekte bei Unverträglichkeits-Reaktionen auf Salicylat-und Additiva-haltige Lebens-mittel. Zbl Haut 153:75–95Google Scholar
  22. 22.
    Henzgen M, Schlenvoigt G, Diener C, Jäger L (1991) Nahrungsmittelallergie bei Frühblüher-pollinose und deren Beeinflussung mittels Hyposensibilisierung. Allergologie 14:90–9Google Scholar
  23. 23.
    Hjorth N, Roed-Petersen J (1976) Occupational protein contact dermatitis in food handlers. Contact Dermatitis 2:28–42PubMedCrossRefGoogle Scholar
  24. 24.
    Holt PG (1998) Mucosal immunity in relation to the development of tolerance/sensitization. Allergy 53:6–19CrossRefGoogle Scholar
  25. 25.
    Host A (1991) Importance of the first meal on the development of cow’s milk allergy and intolerance. Allergy Proc 12:27–32CrossRefGoogle Scholar
  26. 26.
    Hourihane JO, Kilburn A, Dean P, Warner JO (1997) Clinical characteristics of peanut allergy. Clin Exp Allergy 27:634–639PubMedCrossRefGoogle Scholar
  27. 27.
    Isolauri E (2001) Probiotics in the prevention and treatment of allergic disease. Pediatr Allergy Immunol 12[Suppl 14]:56–59PubMedCrossRefGoogle Scholar
  28. 28.
    Jäger L, Wüthrich B (1998) Nahrungsmittelallergien und-intoleranzen. Gustaf Fischer, UlmGoogle Scholar
  29. 29.
    Jarisch R, Pirker C, Möslinger T, Götz M (1997) The role of histamine in wine intolerance. J Allergy Clin Immunol 89:197Google Scholar
  30. 30.
    Jorde W (1980) Orale Desensibilisierung. In: Fillipp G (ed) Allergologie, vol 2. Banaschewski, Munich, pp 53Google Scholar
  31. 31.
    Kanny G, Hatahet R, Moneret-Vautrin A, Kohler C, Bellut A (1994) Allergy and intolerance to flavouring agents in atopic dermatitis in young children. Allerg Immunol 6:204–210Google Scholar
  32. 32.
    Klaschka F (1987) Hämatogenes Kontaktekzem durch Nahrungsmittel. Allergologie 10:93–96Google Scholar
  33. 33.
    Kurek M, Janowska E (2001) Allergische und pseudoallergische Reaktionen auf Aromastoffe in der Nahrung. Z Hautkrankheiten H+G 76:699–703Google Scholar
  34. 34.
    Mempel M, Rakoski J, Ring J, Ollert M (2003) Severe anaphylaxis to kiwi fruit: Immunologic changes related to successful sublingual allergen immunotherapy. J Allergy Clin Immunol 111: 1406–1409PubMedCrossRefGoogle Scholar
  35. 35.
    Möller C (1989) Effect of pollen immunotherapy on food hypersensitivity in children with birch pollinosis. Ann Allergy 62:343–345PubMedGoogle Scholar
  36. 36.
    Montes RG, Perman JA (1991) Lactose intolerance: pinpointing the source of nonspecific gastrointestinal symptoms. Postgrad Med 89:175–178PubMedGoogle Scholar
  37. 37.
    Niggemann B, Reibel S, Roehr CC, et al. (2001) Predictors of positive food challenge outcome in non-IgE-mediated reactions to food in children with atopic dermatitis. J Allergy Clin Immunol 106:1053–1058CrossRefGoogle Scholar
  38. 38.
    Nordlee JA, Taylor SL, Townsend JA, Thomas LA, Bush RK (1996) Identification of a Brazilnut allergen in transgenic soybeans. N Engl J Med 334: 688–692PubMedCrossRefGoogle Scholar
  39. 39.
    Ortolani C, Ballmer-Weber BK, Hansen KS, et al. (2000) Hazelnut allergy: a double-blind, placebo-controlled food challenge multicenter study. J Allergy Clin Immunol 105:577–581PubMedCrossRefGoogle Scholar
  40. 40.
    Pichler WJ, Stich O (1993) Nahrungsmittelallergien bei Pollensensibilisierungen, part II: Kreuzreaktionen bei Beifußpollen-Sensibilisierungen. Allergologie 16:494–501Google Scholar
  41. 41.
    Pratschke E (1986) Mediatoren der immunologischen Stimulation gastraler Funktionen: Experimentelle Untersuchungen am Beispiel der Gastrinfreisetzung. Habilitationsschrift, MünchenGoogle Scholar
  42. 42.
    Przybilla B, Ring J (1990) Food allergy and atopic eczema. Semin Dermatol 9:220–225PubMedGoogle Scholar
  43. 43.
    Reimann HJ, Ring J, Ultsch B, Wendt P (1985) Intragastral provocation under endoscopic control (IPEC) in food allergy. Clin Allergy 15:195–202PubMedCrossRefGoogle Scholar
  44. 44.
    Ring J (1984) Nahrungsmittelallergie und andere Unverträglichkeitsreaktionen durch Nahrungsmittel. Klin Wochenschr 62:795–802PubMedCrossRefGoogle Scholar
  45. 45.
    Ring J (1999) Nahrungsmittel-Allergie und Gentechnik. In: Steinhart H, Tanner W (eds) Bayerische Akademie der Wissenschaften. Rundgespräche der Kommission für Ökologie, vol 16. Lebensmittel und Gentechnik. Dr. Friedrich Pfeil, Munich, pp 61–72Google Scholar
  46. 46.
    Ring J (1997) Gentechnologie und Lebensmittelallergie (DGAI-Stellungnahme). Allergo J 6:214Google Scholar
  47. 47.
    Ring J, Braun-Falco O (1987) Allergie-Diät Verfahren zur Diagnostik und Therapie von Nahrungsmittel-Allergien und-Pseudo-Allergien. Hautarzt 38:198–205PubMedGoogle Scholar
  48. 48.
    Roe DA (1986) Nutrition and the skin. Liss, New YorkGoogle Scholar
  49. 49.
    Sampson HA (2001) Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 107:891–896PubMedCrossRefGoogle Scholar
  50. 50.
    Schäfer T, Bohler E, Ruhdorfer S, et al. (2001) Epidemiology of food allergy/food intolerance in adults: associations with other manifestations of atopy. Allergy 56:1172–1179PubMedCrossRefGoogle Scholar
  51. 51.
    Schauder P, Ollenschläger G (2002) Ernährungsmedizin. Prävention und Therapie, 2nd edn. Urban & Fischer, MunichGoogle Scholar
  52. 52.
    Schindler H, Bräckle J, Karch B (1981) Kochbuch für Allergiker. Ehrenwirth, MunichGoogle Scholar
  53. 53.
    Seifert J, Ring J, Brendel W (1975) Prolongation of skin allografts after oral application of antilymphocyte serum in rats. Nature 249:776CrossRefGoogle Scholar
  54. 54.
    Stefanini GF, Saggioro A, Alvisi V, et al. (1995) Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol 30:535–541PubMedCrossRefGoogle Scholar
  55. 55.
    Stevenson DD, Simon RA 1981) Sensitivity to ingested metabisulphites in asthmatic subjects. J Allergy Clin Immunol 68:26–32PubMedCrossRefGoogle Scholar
  56. 56.
    Strobel S, Hourihane JO (2001) Gastrointestinal allergy: clinical symptoms and immunological mechanisms. Pediatr Allergy Immunol 12[Suppl 14]:43–46PubMedCrossRefGoogle Scholar
  57. 57.
    Thiel CL, Fuchs E (1981) Über korrelative Beziehungen bei Kräuterpollen-und Gewürzallergenen, RAST 3. Berichtsband. Grosse, Berlin, pp 178–185Google Scholar
  58. 58.
    Turjanmaa K (2001) Atopy patch test, an additional new tool in the diagnosis of food allergy. Acta Dermatovenerol Croat 9:69–71Google Scholar
  59. 59.
    Vieths S, Meyer AH, Ehlers I, et al. (2001) Zur Deklaration “versteckter Allergene” in Lebensmitteln. Allergo J 10:130–136Google Scholar
  60. 60.
    Wagner G, Ring J (1981) Anaphylaktische Reaktionen bei Nuß-und Mohnallergie. Notfallmedizin 7:361Google Scholar
  61. 61.
    Wahn U, Seger R, Wahn V (1999) Pädiatrische Allergologie und Immunologie, 3rd edn. Urban & Fischer, MunichGoogle Scholar
  62. 62.
    Warin RP, Smith RJ (1975) Challenge test battery in chronic urticaria. Br J Dermatol 94:401–406CrossRefGoogle Scholar
  63. 63.
    De Weck AL, Griot-Wenk M, Schneider H, et al. (2002) Human allergogeneticists should listen to their dog’s barking. In: Ring J, Behrendt H (eds) New trends in allergy V. Springer, Berlin Heidelberg New York, pp 27–36Google Scholar
  64. 64.
    Werfel T (2000) Allergenspezifische T-Zell-Antwort bei Ekzemkrankheiten. Dustri, München-DeisenhofenGoogle Scholar
  65. 65.
    Werfel T, Wedi B, Kleine-Tebbe J, et al. (1999) Vorgehen bei Verdacht auf eine pseudoallergische Reaktion auf Nahrungsmittelinhaltsstoffe. Allergo J 8:135–341Google Scholar
  66. 66.
    Werner M (1967) Krankheiten infolge peroraler Allergeninvasion. In: Hansen K, Werner M (eds) Lehrbuch der klinischen Allergie. Thieme, Stuttgart, p 179Google Scholar
  67. 67.
    Wüthrich B (1986) Nahrungsmittelallergien. Internist 27:362–371PubMedGoogle Scholar
  68. 68.
    Wüthrich B, Ballmer-Weber BK (2001) Food-induced anaphylaxis. Allergy 56[Suppl 67]:102–104PubMedCrossRefGoogle Scholar
  69. 69.
    Wüthrich B (2000) Lethal or life-threatening allergic reactions to food. J Invest Allergol Clin Immunol 10:59–65Google Scholar
  70. 70.
    Wüthrich B (2002) Nahrungsmittel und Allergie. Dustri, München-DeisenhofeGoogle Scholar

References

  1. 1.
    Albrecht I, Eichler G, Müller U, Hoigné R (1980) On the significance of severe local reactions to hymenoptera stings. Clin Allergy 10:675CrossRefGoogle Scholar
  2. 2.
    Barnard JH (1973) Studies of 400 hymenoptera sting deaths in the United States. J Allergy Clin Immunol 52:259PubMedCrossRefGoogle Scholar
  3. 3.
    Bauer CP (1986) Stichprovokationen zur Diagnostik von Insektengift-Allergien? Allergologie 9:14Google Scholar
  4. 4.
    Benson R, Semenov H (1930) Allergy in its relation to bee sting. J Allergy 1:105CrossRefGoogle Scholar
  5. 5.
    Benton AW, Morse RA, Stewart JD (1963) Venom collection from honey bees. Science 142:228PubMedCrossRefGoogle Scholar
  6. 6.
    Brehler R (1999) Ultra-Rush-Hyposensibilisierung. Allergologie 22[Suppl 2]:570–571Google Scholar
  7. 7.
    Brockow K, Kiehn M, Riethmüller C, et al. (1997) Efficacy of antihistamine treatment in the prevention of adverse reactions to Hymenoptera immunotherapy: A prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 100:458–463PubMedCrossRefGoogle Scholar
  8. 8.
    De Bandt M, Atassi-Dumont M, Kahn MF, et al. (1997) Serum sickness after wasp venom immunotherapy: clinical and biological study. J Rheumatol 24:1195–1197PubMedGoogle Scholar
  9. 9.
    Forck G, Kästner H, Kalveram C (1981) Insect venom tolerance: IgG-“blocking” antibodies and sting provocation. In: Ring J, Burg G (eds) New trends in allergy. Springer, Berlin Heidelberg New York, p 269Google Scholar
  10. 10.
    Fuchs E (1959) Allergie. Münch Med Wochenschr 100:1711Google Scholar
  11. 11.
    Golden DBK, Valentine MD, Kagey-Sobotka A, Lichtenstein ML (1982) Prevalence of hymenoptera venom allergy. J Allergy Clin Immunol 69:124CrossRefGoogle Scholar
  12. 12.
    Habermann E (1972) Bee and wasp venoms. Science 177:314PubMedCrossRefGoogle Scholar
  13. 13.
    Hemmer W, Focke M, Jarisch R (1999) In-vitro-Doppelpositivität gegen Bienen-und Wespengift. Allergologie 22[Suppl 2]:63–64Google Scholar
  14. 14.
    Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM (1978) A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 299:157PubMedCrossRefGoogle Scholar
  15. 15.
    Jarisch R (1980) Die Bienengiftallergie (Modell einer IgE-mediierten Soforttypallergie). Wien Klin Wochenschr 92[Suppl 122]:3Google Scholar
  16. 16.
    Jeßberger B, Habig J, Karl S, et al. (1994) Hymenopterengiftallergie: Hyposensibilisierungstherapie trotz vorhandener Kontraindikationen. Allergologie 17:255–260Google Scholar
  17. 17.
    Kämmerer H (1941) Fragekasten. Münch Med Wochenschr 88:939Google Scholar
  18. 18.
    Kiehn M, Ring J (1993) Hyposensibilisierung mit Insektengiftextrakten bei Patienten mit Hymenopterengift-Allergie im höheren Lebensalter. Allergo J 2[Suppl 2]:90–94Google Scholar
  19. 19.
    King TP, Lu G, Gonzalez M, Qian N, Soldatova L (1996) Yellow jacket venom allergens, hyaluronidase and phospholipase: Sequence similarity and antigenic cross-reactivity with their hornet and wasp homologues and possible implications for clinical allergy. J Allergy Clin Immunol 98:588–600PubMedCrossRefGoogle Scholar
  20. 20.
    Lerch E, Müller UR ((1998) Long-term protection after stopping venom immunotherapy: results of restings in 200 patients. J Allergy Clin Immunol 101:606–612PubMedCrossRefGoogle Scholar
  21. 21.
    Lessof M, Sobotka AK, Lichtenstein LM (1976) Protection against anaphylaxis in hymenopterasensitive patients by passive immunization. J Allergy Clin Immunol 57:246Google Scholar
  22. 22.
    Lichtenstein LM, Valentine MD, Sobotka AK (1974) A case for venom treatment in anaphylactic sensitivity to hymenoptera sting. N Engl J Med 290:1223PubMedCrossRefGoogle Scholar
  23. 23.
    Light WV, Reismann RE, Rosario NA, Arbesman CE (1976) Comparison of the allergenic properties of bee venom and whole bee body extract. Clin Allergy 6:293PubMedCrossRefGoogle Scholar
  24. 24.
    Lockey RF (1975) Systemic reactions to stinging ants. J Allergy Clin Immunol 54:132CrossRefGoogle Scholar
  25. 25.
    Lonsdorf G, Ring J, Burg G (1981) Anaphylaktische Reaktionen nach Insektenstichen. Notfall Medizin 7:409Google Scholar
  26. 26.
    Lotter G (1939) Sensibilisierung für Bienengift durch Typhus-Antitoxin und Desensibilisierung mit Forapin. Münch Med Wochenschr 86:330–33Google Scholar
  27. 27.
    Loveless MH, Fackler WR (1956) Wasp venom allergy and immunity. Ann Allergy 14:347PubMedGoogle Scholar
  28. 28.
    Mauss V (1999) Einfluß von Lebensweise, Populationsdynamik und Abwehrverhalten aculeater Hymenopteren auf das Stichrisiko für den Menschen. Allergologie 22 [Suppl]:542–545Google Scholar
  29. 29.
    Mauss V, Treiber R (1994) Betreuungsschlüssel für die Faltenwespen (Hymenoptera: Masarinae, Polistinae, Vespinae) der Bundesrepublik Deutschland. Deutscher Jugendbund für Naturbeobachtung, HambuGoogle Scholar
  30. 30.
    Mueller HL, Schmid WH, Rubinstein R (1975) Stinging-insect hypersensitivity. A 20-year old study of immunologic treatment. Pediatrics 55:530PubMedGoogle Scholar
  31. 31.
    Müller UR (1988) Insektenstichallergie. Klinik, Diagnostik und Therapie. G. Fischer, StuttgartGoogle Scholar
  32. 32.
    Müller U ((2001) New development in the diagnosis and treatment of hymenoptera venom allergy. Int Arch Allergy Immunol 124:447–499PubMedCrossRefGoogle Scholar
  33. 33.
    Müller U, Mosbech H ((1993) Position paper: Immunotherapy with hymenoptera venoms. Allergy 48[Suppl 2]:37–46CrossRefGoogle Scholar
  34. 34.
    Mumcuoglu Y, Rufli T (1980) Dermatologische Entomologie. 12. Apidael Bienen. 13. Vespidae Wespen. Schweiz Rundsch Med 69:1317, 1574Google Scholar
  35. 35.
    O’Connor R, Peck ML (1978) Venoms of Apidae. In: Handbook of experimental pharmacology, vol 48. Springer, Berlin Heidelberg New York, p 613Google Scholar
  36. 36.
    Ollert M, Ring J (1999) Prognostische Bedeutung von Immunoblot-Untersuchungen bei Hymenopterengift-Allergie. Allergologie 22[Suppl 2]: 578–579Google Scholar
  37. 37.
    Parrish HM (1963) Analysis of 460 fatalities from venomous animals in the United States. Am J Med Sci 245:129PubMedCrossRefGoogle Scholar
  38. 38.
    Przybilla B, Ring J, Galosi A, Geursen RG, Stickl HA (1986) Bee-venom immunoglobulin for prophylaxis of anaphylactic reactions during bee venom immunotherapy (rush hyposensitization). Immunol Allergy Practice 8:107–111Google Scholar
  39. 39.
    Przybilla B (1986) Pathophysiologische und klinische Aspekte der allergischen Reaktion vom Soforttyp und der Immunglobulin-E-Immunantwort: Untersuchungen unter besonderer Berücksichtigung der Bienen-und Wespengiftallergie. Habilitationsschrift, MunichGoogle Scholar
  40. 40.
    Przybilla B, Ring J, Grießhammer B, Braun-Falco O (1987) Schnellhyposensibilisierung mit Hymenopterengiften-Verträglichkeit und Therapieerfolg. Dtsch Med Wochenschr 112:416PubMedCrossRefGoogle Scholar
  41. 41.
    Przybilla B, Ring J, Rieger B (1992) Die Indikation zur Hymenopterengift-Hyposensibilisierung kann nicht anhand eines diagnostischen Parameters bewertenden Punkteschemas gestellt werden. Allergologie 13:114–119Google Scholar
  42. 42.
    Rakoski J, Mayenburg J von (1986) Das Ultra-Rush-Verfahreneine-eine neue Methode zur Über-prüfung der Aktualität von Insektengiftallergien. Allergologie 9:73–74Google Scholar
  43. 43.
    Ring J, Lonsdorf G, Schury W, Burg G (1982) Bienen-und Wespengift-Allergie. Klinik Prophylaxe und Therapie. Münch Med Wochenschr 124:587Google Scholar
  44. 44.
    Ring J, Gottsmann M, Przybilla B, Eisenmenger W (1986) Tod nach 1000 Bienenstichen. Münch Med Wochenschr 128:339Google Scholar
  45. 45.
    Ring J, Przybilla B, Müller U ((1997) Insektengiftallergie: Aktuelles für die Praxis. Allergo J 6[Suppl 1]:571–57Google Scholar
  46. 46.
    Rueff F, Reißig J, Przybilla B (1997) Nebenwirkungen der Schnellhyposensibilisierung mit Hymenopterengift. Allergo J 6[Suppl 1]:659–664Google Scholar
  47. 47.
    Rueff F, Przybilla B, Fuchs T, Gall H, Rakoski J, Stolz W, Vieluf D (2000) Diagnose und Therapie der Bienen-und Wespengiftallergie. Positionspapier der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAI). Allergo J 9:458–472Google Scholar
  48. 48.
    Rzany B, Przybilla B, Jarisch R, et al (1991) Clinical characteristics of immunotherapy with Hymenoptera venoms. A retrospective study. Allergy 46:251–254PubMedCrossRefGoogle Scholar
  49. 49.
    Schäfer T, Przybilla B (1996) IgE antibodies to hymenoptera venoms in the serum are common in the general population and are related to indications of atopy. Allergy 51:372–377PubMedGoogle Scholar
  50. 50.
    Schumacher MJ, Tveten MS, Egen NB (1994) Rate and quantity of delivery of venom from honeybee stings. J Allergy Clin Immunol 93:831–835PubMedCrossRefGoogle Scholar
  51. 51.
    Schuberth KC, Golden DBK, Kagey-Sobotka A, Valentine M, Lichtenstein LM (1981) Evaluation and treatment of insect sting allergy. In: Ring J, Burg G (eds) New trends in allergy. Springer, Berlin Heidelberg New York, p 260Google Scholar
  52. 52.
    Settipane GA, Newstead GJ, Boyd GK (1972) Frequency of hymenoptera allergy in an atopic and normal population. J Allergy Clin Immunol 50:176CrossRefGoogle Scholar
  53. 53.
    Stibich AS, Carbonaro PA, Schwartz RA (2001) Insect bite reactions: an update. Dermatology 202:193–197PubMedCrossRefGoogle Scholar
  54. 54.
    Tokura Y (1994) Lymphocyte populations associated with exaggerated insect bite reactions. J Am Acad Dermatol 31:298PubMedCrossRefGoogle Scholar
  55. 55.
    Tunget CL, Clark RF (1993) Invasion of the “killer” bees. Separating fact from fiction. Postgrad Med 94:92–102PubMedGoogle Scholar
  56. 56.
    Urbanek R (1979) Neue Konzepte der Behandlung von Insektengiftallergien. Derm Beruf Umwelt 27:44PubMedGoogle Scholar
  57. 57.
    Van der Zwan JC, Flintermann J, Jankowski IG, et al. (1983) Hyposensitisation to wasp venom in six hours. Br Med J 287:1329–1331CrossRefGoogle Scholar
  58. 58.
    Weed RI (1965) Exaggerated delayed hypersensitivity to mosquito bite in chronic lymphocyte leukemia. Blood 26:257–268PubMedGoogle Scholar

References

  1. 1.
    Abelson MB, Schaefer K (1993) Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy. Surv Ophthalmol 38:115–132PubMedCrossRefGoogle Scholar
  2. 2.
    Allansmith MR (1982) The eye and immunology. Mosby, St. LouisGoogle Scholar
  3. 3.
    Allansmith MR, Ross RN (1986) Ocular allergy and mast cell stabilizers. Surv Ophthalmol 30:229–244PubMedCrossRefGoogle Scholar
  4. 4.
    Anderson DF (1996) The conjunctival late-phase reaction and allergen provocation in the eye. Clin Exp Allergy 26:1105–1107PubMedCrossRefGoogle Scholar
  5. 5.
    Bialasiewicz AA (1998) Augenheilkunde. In: Heppt W, Renz H, Röcken M (eds) Allergologie. Springer, Berlin Heidelberg New York, pp 262–271Google Scholar
  6. 6.
    Bielory L (2000) Allergic and immunologic disorders of the eye, part II: ocular allergy. J Allergy Clin Immunol 106:1019–1032PubMedCrossRefGoogle Scholar
  7. 7.
    Bonini S, Bucci MG, et al. (1990) Allergen dose response and late symptoms in a human model of ocular allergy. J Allergy Clin Immunol 86/6: 869–876CrossRefGoogle Scholar
  8. 8.
    Bonini S, Bonini S, Lambiase A, et al. (2000) Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology 107:1157–1163PubMedCrossRefGoogle Scholar
  9. 9.
    Foster CS, Rice BA, Dutt JE (1991) Immunopathology of atopic keratoconjuncitivitis. Ophthalmology 98:1190–1196PubMedGoogle Scholar
  10. 10.
    Friedlaender MH (1988) Contact allergy and toxicity in the eye. Int Ophthalmol Clin 28/4:317–320CrossRefGoogle Scholar
  11. 11.
    Friedlaender MH (1993) Allergy and immunology of the eye. Raven, New YorkGoogle Scholar
  12. 12.
    Fuchs E (1905) Über sympathisierende Entzündung. Albrecht v. Graefes Arch Ophthal 61:365CrossRefGoogle Scholar
  13. 13.
    Hatinen A, Terasvirta M, Fakj JE (1985) Contact allergy to components in topical ophthalmologic preparations. Acta Ophthalmol 63:424–426CrossRefGoogle Scholar
  14. 14.
    Jay JL (1981) Clinical factors and diagnosis of atopic keratoconjunctivitis and the effect of treatment with sodium cromoglycate. Br J Ophthal 60:335–340CrossRefGoogle Scholar
  15. 15.
    McGill J (2000) Conjunctival cytokines in ocular allergy. Clin Exp Allergy 30:1355–1357PubMedCrossRefGoogle Scholar
  16. 16.
    Montan PG, Biberfeld PJ, Scheynius A (1995) IgE, IgE receptors and other immunocytochemical markers in atopic and nonatopic patients with vernal keratoconjunctivitis. Ophthalmology 102: 725–732PubMedGoogle Scholar
  17. 17.
    Neuhann T (1983) Papillomatös-hyperplastische Konjunktivitis durch Kontaktlinsen. Mbl Augenheilkunde 8:46–50CrossRefGoogle Scholar
  18. 18.
    Ring I, Dechant W, Seifert J, Lund O-E, Grette J-H, Stefani FH, Brendel W (1978) Immunosuppression with antilymphocyte globulin (ALG) in the treatment of ophthalmic disorders. Ophthal Res 10:82–97CrossRefGoogle Scholar
  19. 19.
    Silverstein AM, O’Connor GR (eds) (1979) Immunology and immunopathology of the eye. Masson, New YorkGoogle Scholar
  20. 20.
    Solomon A, Pe’er J, Levi-Schaffer F (2001) Advances in ocular allergy: basic mechanisms, clinical patterns and new therapies. Curr Opin Allergy Clin Immunol 1:477–482PubMedCrossRefGoogle Scholar
  21. 21.
    Theodore FH, Schlossmann A (1958) Ocular allergy. Williams & Wilkins, BaltimoreGoogle Scholar
  22. 22.
    Trocme SD, Aldave AJ (1994) The eye and the eosinophil. Surv Ophthalmol 39:241–252PubMedCrossRefGoogle Scholar

References

  1. 1.
    Ackroyd JF (1952) Sedormid purpura: An immunological study of drug hypersensitivity. Progr Allergy 3:531Google Scholar
  2. 2.
    Aster RH (1995) Heparin-induced thrombocytopenia and thrombosis. N Engl J Med 332: 1374–1376PubMedCrossRefGoogle Scholar
  3. 3.
    Belongia EA, Hedberg CW, Gleich GJ (1990) An investigation into the cause of the eosinophilia myalgia syndrome associated with tryptophan use. N Engl J Med 323:357–365PubMedCrossRefGoogle Scholar
  4. 4.
    Berg PA, Becker EW (1995) The lymphocyte transformation test-a debated method for the evaluation of drug allergic hepatic injury. J Hepatol 22:115–118PubMedCrossRefGoogle Scholar
  5. 5.
    Brendel W, Ring J (1980) Transplantationsimmunologie. In: Filipp G (ed) Allergologie. Banaschewski, Munich, p 436Google Scholar
  6. 6.
    Dukes MNG (1998) Drug-induced hepatic injury. Elsevier, AmsterdamGoogle Scholar
  7. 7.
    Greinacher A, Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C (1994) Heparin in associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 71:247–251PubMedGoogle Scholar
  8. 8.
    Jäger L, Merk HF (1996) Arzneimittel-Allergie. Gustav Fischer, JenaGoogle Scholar
  9. 9.
    Kelton JG, Huang AT, Mold N (1979) The use of in vitro techniques to study drug-induced pancytopenia. N Engl J Med 301:621PubMedCrossRefGoogle Scholar
  10. 10.
    Landsteiner K (1901) Wien Klin Wochenschr 14:1132Google Scholar
  11. 11.
    Manns M (1989) Autoantibodies and antigens in liver diseases-updated. J Hepatol 9:272–280PubMedCrossRefGoogle Scholar
  12. 12.
    Maria VAJ, Pinto L, Victorino RMM (1994) Lymphocyte reactivity to ex-vivo drug antigens in drug-induced hepatitis. J Hepatol 21:151–158PubMedCrossRefGoogle Scholar
  13. 13.
    Mueller-Eckhardt C (1988) Ex vivo drug antigens. Are drug-induced immunoreactions such as immunohemolytic anemia related to genetic control? In: Estabrook RW, Lindenlaub E, Oesch F, Weck AL de (eds) Toxicological and immunological aspects of drug metabolism and environmental chemicals. Schattauer, Stuttgart, pp 329–342Google Scholar
  14. 14.
    Mueller-Eckhart C, Kuenzlen E, Thilo-Korner D, Pralle H (1983) High-dose intravenous immunoglobulin for post transfusion purpura. N Engl J Med 308:287Google Scholar
  15. 15.
    Mueller-Eckhardt C, Salama A (1987) Immunhämolytische Anämien durch Medikamente. Dtsch Ärztebl 84:232–234Google Scholar
  16. 16.
    Neftel KA, Wälti M, Spengler H, Felten A von, Weitzmann SA, Bürgi H, Weck AL de (1981) Neutropenia after penicillins: toxic or immune-mediated? Klin Wochenschr 59:877PubMedCrossRefGoogle Scholar
  17. 17.
    Pessayre D (1995) Mecanisme de hepatites medi-camenteuses Gastroenterol. Clin Biol 19:47–56Google Scholar
  18. 18.
    Pihusch R (1998) Die Heparin-induzierte Thrombozytopenie. Phlebologie 27:111–116Google Scholar
  19. 19.
    Plötz G, et al. Hypereosinophilie-Syndrom. HautarztGoogle Scholar
  20. 20.
    Raif W, Schubothe H (1979) Durch körperfremde Substanzen induzierte immunhämatologische Erkrankungen. Allergologie 2:192Google Scholar
  21. 21.
    Raskob GE, George JN (1997) Thrombotic complications of antithrombotic therapy: a paradox with implications for clinical practice. Ann Intern Med 127:839–841PubMedGoogle Scholar
  22. 22.
    Salama A, Mueller-Eckhardt C (1985) The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia. N Engl J Med 313:469–474PubMedCrossRefGoogle Scholar
  23. 23.
    Salama A, Mueller-Eckhardt C (1992) Humanemediated blood cell dyscrasias related to drugs. Semin Hematol 29:54–63PubMedGoogle Scholar
  24. 24.
    Schiele F, Vuillemenot A, Kramarz P, Kieffer Y, Anguenot T, Bernard Y, Bassand JP (1995) Use of recombinant hirudin as antithrombotic treatment in patients with heparin induced thrombocytopenia. Ann J Hematol 50:20–25CrossRefGoogle Scholar
  25. 25.
    Shulman NR, Aster RH, Leitner A, Hiller MC (1961) Immunoreactions involving platelets. V. Posttransfusion purpura due to a complement-fixing antibody against a genetically controlled platelet antigen. J Clin Invest 40:1597PubMedCrossRefGoogle Scholar
  26. 26.
    Shulman NR (1972) Immunologic reactions to drugs. N Engl J Med 286:508–512Google Scholar
  27. 27.
    Varga J, Uitto J, Jimenez SA (1992) The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann Int Med 116:140–147PubMedGoogle Scholar
  28. 28.
    Wanamaker WM, Wanamaker SJ, Celesia GG, et al. (1976) Thrombocytopenia associated with long-term levodopa therapy. J Am Med Assoc 235:2217CrossRefGoogle Scholar
  29. 29.
    Zweiman B, Patten E (1982) Immunohematologic diseases. J Am Med Assoc 248:2677–2682CrossRefGoogle Scholar

References

  1. 1.
    Becker EL, Austen KF (1966) Mechanisms of immunologic injury of rat peritoneal mast cells. I. The effect of phosphonate inhibitors on the homcytotropic antibody-mediated histamine release and the first component of rat complement. J Exp Med 124:379–395PubMedCrossRefGoogle Scholar
  2. 2.
    Brostoff J, Challacombe SJ (eds) (1987) Food allergy and intolerance. Tindall, LondonGoogle Scholar
  3. 3.
    Bruckbauer HR, Ollert M, Ring J (1997) Vaskulitiden der Haut. Bay Int 17:166–179Google Scholar
  4. 4.
    Burden AD, Tillman DM, Foley P, Holme E (1996) IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol 35:411–415PubMedCrossRefGoogle Scholar
  5. 5.
    Cochrane CG, Koftler D (1973) Immune complex disease in experimental animals and man. Adv Immunol 16:185PubMedCrossRefGoogle Scholar
  6. 6.
    Dixon FJ, Vasquez JJ, Weigle WO, Cochrane CG (1958) Pathogenesis of serum sickness. Arch Pathol 65:18Google Scholar
  7. 7.
    Eisenmann A, Ring J, von der Helm D, Meurer M, Braun-Falco O (1988) Vasculitis allergica durch Nahrungsmittelallergie. Hautarzt 39:318–321PubMedGoogle Scholar
  8. 8.
    Fauci AS (1979) Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med 301:235PubMedGoogle Scholar
  9. 9.
    Gross WL, Schmitt WH, Lotti T (1995) ANCA-assoziierte Vaskulitiden. Hautarzt 46:511–524PubMedCrossRefGoogle Scholar
  10. 10.
    Hunt HJ, Valentine MD, Sobotha AK, Junginger JW, Lichtenstein LM (1976) Serum sickness associated with nonvenom protein in mixed hymenoptera whole body extract. J Allergy Clin Immunol 57:246–254Google Scholar
  11. 11.
    Jenette CJ, Milling DM, Falk RJ (1994) Vasculitis affecting the skin. Arch Dermatol 130:899–906CrossRefGoogle Scholar
  12. 12.
    Kohler PF (1983) Immune complexes and allergic disease. In: Middleton E, Ellis EF, Reed CE (eds) Allergy, principles and practice, 2nd edn. Mosby, St. Louis, pp 167–199Google Scholar
  13. 13.
    Meurer M (1981) Urticarial vasculitis. In: Ring J, Burg G (eds) New trends in allergy. Springer, Berlin Heidelberg New York, pp 148–151Google Scholar
  14. 14.
    Morgan AC Jr, Rossen R, Twomey JJ (1979) Naturally occurring circulating immune complexes: normal serum contains idiotype-anti-idotype complexes dissociable by certain IgG antiglobulins. J Immunol 122:1672PubMedGoogle Scholar
  15. 15.
    Ollert, deleted in productionGoogle Scholar
  16. 16.
    Pirquet C v, Schick B (1905) Die Serumkrankheit. Deutike, LeipzigGoogle Scholar
  17. 17.
    Ravetch JV (1994) Fc receptors: Rubor redux. Cell 78:533–560CrossRefGoogle Scholar
  18. 18.
    Ring J, Seifert J, Lob G, Coulin K, Angstwurm H, Frick E, Brass B, Mertin I, Backmund H, Brendel W (1974) Intensive immunosuppression in the treatment of multiple sclerosis. Lancet II:1093CrossRefGoogle Scholar
  19. 19.
    Ring J, Seifert J, Seiler F, Brendel W (1976) Improved compatibility of ALG therapy by application of aggregate free globulin. Int Arch Allergy Appl Immunol 52:227–234PubMedCrossRefGoogle Scholar
  20. 20.
    Ring J (1978) Anaphylaktoide Reaktionen nach Infusion natürlicher und künstlicher Kolloide. Springer, Berlin Heidelberg New YorGoogle Scholar
  21. 21.
    Ruzicka T, Burg G (1987) Effects of chronic intracutaneous administration of arachidonic acid and its metabolites. Induction of leukocytoclastic vasculitis by leukotriene B4 and 12-hydroxyeico-satetraenoic acid and its prevention by prostaglandin E2. J Invest Dermatol 88:120–123PubMedCrossRefGoogle Scholar
  22. 22.
    Sais G, Vidaller A, Jucgla A, Gallardo F, Peyri J (1995) Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial. Arch Dermatol 131:1399–1402PubMedCrossRefGoogle Scholar
  23. 23.
    Scherer R, Wolff HH (1979) Vasculitis allergica. Allergologie 2:62Google Scholar
  24. 24.
    Sedlacek HH (1980) Pathophysiological aspects of immune complex diseases. Klin Wochenschr 58:543–593PubMedCrossRefGoogle Scholar
  25. 25.
    Seifert J, Land W, Ring J, Lob G, Brendel W (1978) Antigen-Eliminationstechnik. Fortschr Med 96: 695–697PubMedGoogle Scholar
  26. 26.
    Smedegard G, Revenas B, Arfors KE (1979) Anaphylaxis in the monkey: hemodynamics and blood flow distribution. Acta Physiol Scand 106: 191–198PubMedCrossRefGoogle Scholar
  27. 27.
    Soter NA, Austen KF, Gigli I (1974) Urticaria and arthralgias as manifestations of necrotizing angiitis (vasculitis). J Invest Dermatol 63:485–490PubMedCrossRefGoogle Scholar
  28. 28.
    Sylvestre DL, Ravetch JV (1994) Fc receptors initiate the Arthus reaction: Redefining the inflammatory cascade. Science 265:1095–1098PubMedCrossRefGoogle Scholar
  29. 29.
    Theissen U, Luger TA, Schwarz T (1996) Erfolgreiche topische Anwendung von Cyclosporin A bei Pyoderma gangraenosum. Hautarzt 47:132–135PubMedCrossRefGoogle Scholar
  30. 30.
    Theofilopoulos AN, Dixon FJ (1980) Detection of immune complexes; techniques and implications. Hosp Pract 15:107PubMedGoogle Scholar
  31. 31.
    van Furth R, Cohn ZA, Hirsch JG, et al. (1972) The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull Wld Hlth Org 46:845Google Scholar
  32. 32.
    Wolff HH, Scherer R (1981) Allergic vasculitis. In: Ring J, Burg G (eds) New trends in allergy. Springer, Berlin Heidelberg New York, pp 140–147Google Scholar
  33. 33.
    Zhang Y, Ramos BF, Jakschik BA (1992) Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 258:1957–1959PubMedCrossRefGoogle Scholar

References

  1. 1.
    Allen DH, Basten A, Woolcock AJ (1977) Studies of cell and humoral immunity in birdbreeders hypersensitivity pneumonitis. Am Rev Resp Dis 115:45Google Scholar
  2. 2.
    Bäck O, Lindgren R, Wiman LG (1974) Nitrofurantoin induced pulmonary fibrosis and lupus syndrome. Lancet I:930CrossRefGoogle Scholar
  3. 3.
    Bergmann KC, Costabel U, Knape H, Kroidl R, Müller-Wening D, Repp H, Rust M, Schwarz H, Sennekamp J (1990b) Empfehlungen zur Diagno-sestellung einer exogen-allergischen Alveolitis. Allergologie 13:111Google Scholar
  4. 4.
    Boyd G, McSharry C, McLeod K, Sriram S, Boyd F (1999) Lymphocyte responses in pigeon breeders with extrinsic allergic alveolitis/hypersensitivity pneumonitis (EAA/HP) are predominantly T helper 2-type. Am J Resp Crit Care Med 159:A742Google Scholar
  5. 5.
    Doerr W (1953) Pneumokoniose durch Getreidestaub. Virchows Arch Pathol Anat 324:263CrossRefGoogle Scholar
  6. 6.
    Fink JN (1992) Hypersensitivity pneumonitis. Clinics in chest Medicine 13:303PubMedGoogle Scholar
  7. 7.
    Fruhmann G (1988b) Pneumokoniosen durch organisches Material. Deutsches Ärzteblatt 85:3170Google Scholar
  8. 8.
    Fuchs A, Liebetrau G (1989) Die Vogelhalterlunge — eine Form der exogen allergischen Alveolitis. Z Klein Med 44:1407Google Scholar
  9. 9.
    Heiner DC, Snears JW, Kniker WT (1962) Multiple precipitins to cow’s milk in chronic respiratory disease. Am J Dis Child 103:634PubMedGoogle Scholar
  10. 10.
    Hinojosa M (2001) Stipatosis or hypersensitivity pneumonitis caused by esparto (Stipa tenacissima) fibers. J Invest Allergol Clin Immunol 11:67–72Google Scholar
  11. 11.
    Jelke G (1986) Krank durch Fortschritt. Expositionelle Besonderheiten bei der exogen-allergischen Alveolitis. Allergologie 9:137Google Scholar
  12. 12.
    Kroidl RF, Nowak D, Seysen U (1994b) Exogen-allergische Alveolitis: Probleme und Fehler bei der Begutachtung. Allergologie 17:75Google Scholar
  13. 13.
    Malmberg P, Rask-Andersen A (1993b) Organic dust toxic syndrome. Semin Resp Med 14:38CrossRefGoogle Scholar
  14. 14.
    Marinkovich VA (1975) Hypersensitivity alveolitis. J Am Med Assoc 231:944CrossRefGoogle Scholar
  15. 15.
    McCarthy DS, Pepys J (1971) Allergic bronchopulmonary aspergillosis. Clinical immunology: 1. Clinical features, 2. Skin, nasal and bronchial tests. Clin Allergy 1:261, 415CrossRefGoogle Scholar
  16. 16.
    McSharry C, Banham SW, Boyd G (1985) Effect of cigarette smoking on the antibody response to inhaled antigens and the prevalence of extrinsic allergic alveolitis among pigeon breeders. Clin Allergy 15:487PubMedCrossRefGoogle Scholar
  17. 17.
    Molina C (1984) Immunopathologie bronchopulmonaire. Masson, ParisGoogle Scholar
  18. 18.
    Müller-Wening D, Repp H (1989b) Investigation on the protective value of breathing masks in farmer’s lung using an inhalation provocation test. Chest 95:100PubMedCrossRefGoogle Scholar
  19. 19.
    Murray MJ, et al. (1965) Pulmonary reactions simulating cardiac pulmonary edema caused by nitrofurantoin. N Engl J Med 273:1185PubMedCrossRefGoogle Scholar
  20. 20.
    Newman-Taylor A, Pickering CAC, Turner-Warwick M, Pepys J (1978) Respiratory allergy to a factor humidifier contaminant presenting as pyrexia of undetermined origin. Br Med J:IIGoogle Scholar
  21. 21.
    Olenchock SA, May JJ, Pratt DS, et al. (1990) Presence of endotoxin in different agricultural environments. Am J Industr Med 18:279CrossRefGoogle Scholar
  22. 22.
    Parkers WR (1994) Occupational lung disorders. Butterworth, LondonGoogle Scholar
  23. 23.
    Patterson R (1978d) Studies of hypersensitivity lung disease with emphasis on a solid-phase radioimmunoassay as a potential diagnostic acid. J Allergy Clin Immunol 61:216PubMedCrossRefGoogle Scholar
  24. 24.
    Pepys J (1994) Farmer lung’s — a needle in a haystack, and Pandora’s box. Allergy Clin Immunol News 6:68Google Scholar
  25. 25.
    Pepys I, Jenkins P, Festenstein G, Gregory P, Lacey M, Skinner F (1963) Farmer’s lung. Thermophilic actinomycetes as a source of “farmer’s lung hay” antigen. Lancet II:607CrossRefGoogle Scholar
  26. 26.
    Raulf M, Liebers V, Steppert C, Baur X (1994) Increased gamma/delta positive T-cells in pneumonitis. Eur Respir J 7:140PubMedCrossRefGoogle Scholar
  27. 27.
    Rylander R, Malmberg P (1992a) Non-infectious fever: inhalation fever or toxic alveolitis? Br J Industr Med 49:296Google Scholar
  28. 28.
    Salvaggio JE, Buechner HA, Seabury H (1966) Bagassosis I. Precipitins against extracts of crude bagasse in the serum of patients with bagassosis. Ann Intern Med 64:748Google Scholar
  29. 29.
    Sastre J, Ibanez MD, Lopez M, Lehrer SB (1990) Respiratory and immunological reactions among Shiitake (Lentinus edodes) mushroom workers. Clin Exp Allergy 20:13PubMedCrossRefGoogle Scholar
  30. 30.
    Schatz M, Patterson R (1977) Immunopathogenesis of hypersensitivity pneumonitis. J Allergy Clin Immunol 60:27PubMedCrossRefGoogle Scholar
  31. 31.
    Schulz KH, Felten G, Hausen BM, Noster U (1974) Allergy to spores of Pleurotus Florida. Lancet I:625CrossRefGoogle Scholar
  32. 32.
    Schultze-Werninghaus G, Rust M (1988b) Asthma bronchiale und allergische Alveolitis durch Berufsallergene. Allergologie II:437Google Scholar
  33. 33.
    Seeliger HPR, Sühler H (1975) Farmerlunge beim Tier. Berl Münch Tierärztl Wochenschr 88:163PubMedGoogle Scholar
  34. 34.
    Sennekamp H-J (1998) Exogen allergische Alveolitis. Dustri, MunichGoogle Scholar
  35. 35.
    Slavin RG, Million L, Cherry J (1970) Allergic bronchopulmonary aspergillosis: characterization of antibodies and results of treatment. J Allergy Clin Immunol 46:150Google Scholar
  36. 36.
    van Hage-Hamsten M, Johansson SGO, Höglund S, Tüll P, Wirén A, Zetterström O (1985) Storage mite allergy is common in a farming population. Clin Allergy 15:555–564PubMedCrossRefGoogle Scholar
  37. 37.
    Vogelmeier C, Krombach F, Münzing S, et al. (1993) Activation of blood neutrophils in acute episodes of farmer’ lung. Am Rev Resp Dis 148:396PubMedGoogle Scholar
  38. 38.
    von Essen S, Robbins RA, Thompson AB (1990) Organic dust toxic syndrome. Clin Toxicol 28:389CrossRefGoogle Scholar
  39. 39.
    Warren CPW (1977) Extrinsic allergic alveolitis: a disease commoner in non-smokers. Thorax 32:567–569PubMedCrossRefGoogle Scholar
  40. 40.
    Weck AL de, Gutersohn J, Bütikofer E (1969) La maladie des laveurs de fromage (“Käsewascher-krankheit”): une forme particulière du syndrome du poumon de fermier. Schweiz Med Wochenschr 99:872PubMedGoogle Scholar
  41. 41.
    Westphal O, Lüderitz O (1961) Bacterial endotoxins. J Med Pharma Chem 4:497CrossRefGoogle Scholar
  42. 42.
    Wild LG, Lopez M (2001) Hypersensitivity pneumonitis: A comprehensive review. J Invest Allergol Clin Immunol 11:3–15Google Scholar

References

  1. 1.
    Ackermann AB, Ragaz A (1982) A plea to expunge the word eczema from the lexicon of dermatology and dermatopathology. Am J Dermatopathol 4:315–326Google Scholar
  2. 2.
    Aetius von Amida (1549) Tetrabiblos (V.4, Sermo 1, Kap. 128). Froben, Basel, p 730Google Scholar
  3. 3.
    Akdis M, Klunker S, Schliz M, Blaser K, Akdis CA (2000) Expression cutaneous lymphocyte-associated antigen on human CD4+ and DC8+ Th2 cells. Eur J Immunol 30:3533–3541PubMedCrossRefGoogle Scholar
  4. 4.
    Bandmann HJ, Dohn W (1967) Die Epicutantestung, 2nd edn. Bergmann, MunichGoogle Scholar
  5. 5.
    Benezra C (1986) Molecular recognition in allergic contact dermatitis. In: Ring J, Burg G (eds) New trends in allergy II. Springer, Berlin Heidelberg New York, pp 218–224Google Scholar
  6. 6.
    Bergstresser PR, Tigelaar RE, Dees JH, Streilein JW (1983) Thy-1 antigen-bearing dendritic cells populate murine epidermis. J Invest Dermatol 81:286PubMedCrossRefGoogle Scholar
  7. 7.
    Bloch I (1911) Der älteste Gebrauch des Wortes “Eczema”. Mh Prakt Dermatol 53:69–71Google Scholar
  8. 8.
    Borelli S (1980) Gewerbedermatosen, einschließlich Begutachtung. In: Korting GW (ed) Dermatologie in Praxis und Klinik, vol II. Thieme, StuttgartGoogle Scholar
  9. 9.
    Braathen LR, Thorsby E (1983) Human epidermal Langerhans cells are more potent than blood monocytes in inducing some antigen-specific T cell-responses. Br J Dermatol 108:139–146PubMedCrossRefGoogle Scholar
  10. 10.
    Brasch J, Geier J, Schnuch A (1998) Differenzierte Kontaktallergenlisten dienen der Qualitätsverbesserung. Hautarzt 49:184–191PubMedCrossRefGoogle Scholar
  11. 11.
    Burg G, Przybilla B, Bogner J (1986) Contact — allergy time. In: Ring J, Burg G (eds) New trends in allergy II. Springer, Berlin Heidelberg New York, pp 230–239Google Scholar
  12. 12.
    Bruynzeel DP (1983) Angry back or excited skin syndrome. Thesis, AmsterdamGoogle Scholar
  13. 13.
    Cavani A, Albanesi C, Traidl C, Sebastiani S, Girolomoni G (2001) Effector and regulatory T cells in allergic contact dermatitis. Trends Immunol 22: 118–120PubMedCrossRefGoogle Scholar
  14. 14.
    Chase MW (1946) Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med 61:257–259Google Scholar
  15. 15.
    Cronin E (1980) Contact dermatitis. Churchill Livingstone, EdinburghGoogle Scholar
  16. 16.
    De Groot AC (1994) Patch testing. Elsevier, AmsterdamGoogle Scholar
  17. 17.
    Diepgen TL, Coenraads PJ (1999) The epidemiology of occupational contact dermatitis. Int Arch Occup Environ Health 72:496–506PubMedCrossRefGoogle Scholar
  18. 18.
    Enders F, Przybilla B, Ring J (1988) Epikutantest mit einer Standardreihe. Ergebnisse bei 12 026 Patienten. Hautarzt 39:779–786PubMedGoogle Scholar
  19. 19.
    Enk AH, Angeloni VL, Udey MC, Katz SI (1993) An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J Immunol 150:3698–3703PubMedGoogle Scholar
  20. 20.
    Faergemann J (1993) Pityrosporum ovale-assoziierte Dermatosen. In: Braun-Falco O, Plewig GK, Meurer M (eds) Fortschritte prakt. Derm Venereol, vol 14. Springer, Berlin Heidelberg New York, pp 234–237Google Scholar
  21. 21.
    Fischer T, Bellberg K, Bruynzeel DP, Ducombs G, Hannuksela M, Lachapelle IM, Ring J, White IR, Wilkinson J (1988) European multicenter study of TRUE test. Contact Dermatol 19:91–97CrossRefGoogle Scholar
  22. 22.
    Foussereau J, Benezra C, Maibach HI (1982) Occupational contact dermatitis, clinical and chemical aspects. Munksgaard, CopenhagenGoogle Scholar
  23. 23.
    Frosch P, Rustemeyer T, Schnuch A (1996) Kontaktdermatitis, parts I and II. Hautarzt 47:874–882, 945–961PubMedGoogle Scholar
  24. 24.
    Fuchs T, Aberer W (eds) (2004) Kontakteczema. Dustri, Deisenhofen (in press)Google Scholar
  25. 25.
    Gollhausen R, Ring J, Przybilla B (1987) Der iterative Test zur Unterscheidung kontaktallergischer oder irritativer Epikutantestreaktionen. Allergologie 10:427Google Scholar
  26. 26.
    Grabbe S, Kämpgen E, Schuler G (2000) Dentritic cells: multi-lineal and multi-functional. Immunol Today 21:431–433PubMedCrossRefGoogle Scholar
  27. 27.
    Granstein RD, Askari M (1986) Cutaneous cells in activation of immunologic reactions: further characterization. J Invest Dermatol 87:141Google Scholar
  28. 28.
    Halter S (1959) Das vulgäre Eczema. In: Gottron A, Schönfeld W (eds) Dermatologie und Venerologie, vol III/1. Thieme, StuttgartGoogle Scholar
  29. 29.
    Happle R (1994) Paraptisches Eczema. Hautarzt 45:1–3PubMedCrossRefGoogle Scholar
  30. 30.
    Hausen B, Vieluf I (1998) Allergie-Pflanzen. Pflanzen-Allergene. Ecomed, LandsbergGoogle Scholar
  31. 31.
    Hornstein OP (1986) Anmerkungen und Vorschläge zur Definition und Klassifikation der Eczemakrankheiten. Z Hautkr 61:1281–1296PubMedGoogle Scholar
  32. 32.
    Hannuksela M, Salo H (1986) The repeated open application test (ROAT). Contact Dermatol 14: 211–227CrossRefGoogle Scholar
  33. 33.
    Jadassohn J (1895) Verhandl Dtsch Derm Gesellschaft 5. Kongreß 1896, p 103Google Scholar
  34. 34.
    Kapsenberg ML, Bos JD, Wierenga EA (1992) Cells in allergic responses to haptens and proteins. Springer Semin Immunopathol 13:303–314PubMedCrossRefGoogle Scholar
  35. 35.
    Klaschka F (1987) Hämatogenes Kontakteczema durch Nahrungsmittel. Allergologie 10:93–97Google Scholar
  36. 36.
    Knop J, Malorny U, Macher E (1984) Induction of T effector and T suppressor lymphocytes in vitro by haptenized bone marrow-derived macrophages. Cell Immunol 88:411–420PubMedCrossRefGoogle Scholar
  37. 37.
    Kripke ML, Munn CG, Jeevan A, Tang MM, Bucana C (1990) Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 145: 2833–2842PubMedGoogle Scholar
  38. 38.
    Langerhans P (1868) Über die Nerven der menschlichen Haut. Virchows Arch A (Path Anat) 44:325CrossRefGoogle Scholar
  39. 39.
    Lepoittevin J-P, Benezra C, Sigman CC, Baheri D, Fraginals R, Maibach HI (1995) Molecular aspects of allergic contact dermatitis. In: Rycroft RJG, Mennée T, Frosch P (eds) Textbook of contact dermatitis. Springer, Berlin Heidelberg New York, pp 105–119Google Scholar
  40. 40.
    Luderschmidt C, Heilgemair G, Ring J, Burg G (1982) Polyvalente Kontaktallergie versus “Angry-back-Syndrom”. Allergologie 5:262–268Google Scholar
  41. 41.
    Magnussen B, Kligman AM (1977) Usefulness of guinea pig tests for detection of contact sensitizers. In: Marzulli FN, Maibach HI (eds) Dermatotoxicology and pharmacology. Wiley, London, pp 551–560Google Scholar
  42. 42.
    Maibach HI (1981) The ESS, excited-skin-syndrome (alias the “angry-back”). In: Ring J, Burg G (eds) New trends in allergy. Springer, Berlin Heidelberg New York, pp 206–216Google Scholar
  43. 43.
    Miescher G (1962) In: Marchionini A (ed) Handbuch der Haut-und Geschlechtskrankheiten, supplementary vol 11/1. Springer, Berlin Heidelberg New York, p 1Google Scholar
  44. 44.
    Mitchell JC (1975) The angry back syndrome: eczema creates eczema. Contact Dermatol 1: 193–194CrossRefGoogle Scholar
  45. 45.
    Nater JP, De Groot AC (1983) Unwanted effects of cosmetics and drugs used in dermatology, 2nd edn. Elsevier, AmsterdamGoogle Scholar
  46. 46.
    Odia S, Vocks E, Rakoski J, Ring J (1996) Successful treatment of dyshidrotic hand eczema using tap water iontophoresis with pulsed direct current. Acta Derm Venereol 76:472–474PubMedGoogle Scholar
  47. 47.
    Rietschel RL, Fouler JF (2001) Fisher’s contact dermatitis, 5th edn. Lippincott-Williams, PhiladelphiaGoogle Scholar
  48. 48.
    Ring J (ed) (1990) Endogenous and exogenous eczema. Semin Dermatol 9:195–246Google Scholar
  49. 49.
    Ring J (1996) Zum Wandel des Eczema-Begreiffes: Klassisches versus atopisches Eczema. Z Hautkr 10:752–756Google Scholar
  50. 50.
    Römpp H (1982) Chemielexikon, 8th edn. Franckh’sche Verlagshandlung, StuttgartGoogle Scholar
  51. 51.
    Ross R, Gillitzer R, Kleinz J, Schwing H, Kleinert U, Förstermann AB, Reske-Kunz (1998) Involvement of NO in contact hypersensitivity. Int Immunol 10:61–69PubMedCrossRefGoogle Scholar
  52. 52.
    Rycroft RJG, Menné T, Frosch P (eds) (1995) Textbook of contact dermatitis. Springer, Berlin Heidelberg New YorkGoogle Scholar
  53. 53.
    Schäfer T, Böhler E, Ruhdorfer S, Weigl L, Wessner D, Filipiak B, Wichmann HE, Ring J (2004) Epidemiology of contact allergy in adults. Allergy (in press)Google Scholar
  54. 54.
    Schnuch A, Geier J, Uter W, et al. (1997) National rates and regional differences in sensitization to allergens of the standard series. Contact Dermatitis 37:200–209PubMedCrossRefGoogle Scholar
  55. 55.
    Schnuch A, Aberer W, Agathos M, Brasch J, Frosch PJ, Fuchs T, Richter G (2001) Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG) zur Durchführung des Epikutantests mit Kontaktallergenen. Hautarzt 52:864–866CrossRefPubMedGoogle Scholar
  56. 56.
    Schulz KH, Fuchs T (1993) Der Epikutantest. Manuale allergologicum, IV, 4. Dustri, Deisenhofen, pp 1–39Google Scholar
  57. 57.
    Schuler G, Steinman RM (1985) Murine epidermal Langerhans cells mature into potent immuno-stimulatory dendritic cells in vitro. J Exp Med 161:526–546PubMedCrossRefGoogle Scholar
  58. 58.
    Schwanitz HJ (1986) Das atopische Palmoplantareczema. Springer, Berlin Heidelberg New YorkGoogle Scholar
  59. 59.
    Schwanitz HJ, Szliska C (eds) (2001) Berufsdermatosen. Dustri, MunichGoogle Scholar
  60. 60.
    Scott P (1993) IL-12: initiation cytokine for cell-mediated immunity. Science 260:496–497PubMedCrossRefGoogle Scholar
  61. 61.
    Silberberg I, Baer RI, Rosenthal SA (1974) The role of Langerhans cells in contact allergy. I. An ultrastructural study in actively induced contact dermatitis in guinea pigs. Acta Derm Venereol (Stockh) 54:321–331PubMedGoogle Scholar
  62. 62.
    Stingl G (1980) New aspects of Langerhans cell function. Int J Dermatol 19:189PubMedCrossRefGoogle Scholar
  63. 63.
    Török I (1989) Eczema s betegsegek. Medicina, BudapestGoogle Scholar
  64. 64.
    Traidl C, Merk HF, Cavani A, Hunzelmann N (2000) New insights into the pathomechanisms of contact dermatitis by the use of transgenic mouse models. Skin Pharmacol Appl Skin Physiol 13:300–312PubMedCrossRefGoogle Scholar
  65. 65.
    Unna PG (1887) Seborrhoeal eczema. J Cutan GU Dis 5:449–459Google Scholar
  66. 66.
    Uter W, Schnuch A, Geier J, et al. (1998) Epidemiology of contact dermatitis. The information network of Department of Dermatology (IVDK) in Germany. Eur J Dermatol 8:36–40PubMedGoogle Scholar
  67. 67.
    Willan (1808) On cutaneous diseases. Johnson, LondonGoogle Scholar

References

  1. 1.
    Abeck D, Schmidt T, Fesq H, Strom K, Mempel M, Brockow K, Ring J (2000) Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. J Am Acad Dermatol 42:254–257PubMedCrossRefGoogle Scholar
  2. 2.
    Abeck D, Ring J (eds) (2002) Atopisches Eczema (Neurodermitis) im Kindesalter. Steinkopff, DarmstadtGoogle Scholar
  3. 3.
    Akdis CA, Akdis M, Trautmann A, Blaser K (2000) Immune regulation in atopic dermatitis. Curr Opin Immunol 12:641–646PubMedCrossRefGoogle Scholar
  4. 4.
    Atherton DJ (1981) Allergy and atopic eczema. Clin Exp Dermatol 6:317–325PubMedCrossRefGoogle Scholar
  5. 5.
    Besnier E (1892) Premiere note et observations preliminaires pour servir d’introduction a l’etude des prurigos diathesiques (dermatites multiformes prurigineuses chroniques exacerbantes et paroxystiques, du type du prurigo de Hebra). Ann Derm Syph (Paris) 3,3:634–648Google Scholar
  6. 6.
    Bieber T (1994) FceR1 on human Langerhans cells: a receptor in search of new functions. Immunol Today 15:52–53PubMedCrossRefGoogle Scholar
  7. 7.
    Bleck O, Abeck D, Ring J, Hoppe U, Vietzke J, Wolber R, Brandt O, Schreiner V (1999) Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids on non-lesional skin of atopic eczema. J Invest Dermatol 113:894–900PubMedCrossRefGoogle Scholar
  8. 8.
    Boguniewicz M, Leung DYM (1998) Atopic dermatitis: A question of balance. Arch Dermatol 134:870–871PubMedCrossRefGoogle Scholar
  9. 9.
    Bos JD, Van Leent EJ, Sillevis Smitt JH (1998) The millennium criteria for the diagnosis of atopic dermatitis. Exp Dermatol 7:132–138PubMedCrossRefGoogle Scholar
  10. 10.
    Borelli S, Schnyder UW (1962) Neurodermitis constitutionalis sive atopica, part II: Atiologie, Pathophysiologie, Pathogenese, Therapie. In: Miescher G, Storck H (eds) Entzündliche Dermatosen I. Handbuch der Haut-und Geschlechts-krankheiten [Suppl 11/1]. Springer, Berlin Heidelberg New York, pp 254–319Google Scholar
  11. 11.
    Braun-Falco O, Ring J (1984) Zur Therapie des atopischen Eczemas. Hautarzt 35:447–454PubMedGoogle Scholar
  12. 12.
    Bruynzeel-Koomen C, Van Wichen DF, Toonstra J, Berrens L, Bruynzeel PLB (1986) The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res 278:199–205PubMedCrossRefGoogle Scholar
  13. 13.
    Carucci JA, Washenik K, Weinstein A, Shupack J, Cohen DE (1998) The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch Dermatol 134:785–786PubMedCrossRefGoogle Scholar
  14. 14.
    Cooper KD, Stevens SR (2001) T cells in atopic dermatitis. J Am Acad Dermatol 45:510–512CrossRefGoogle Scholar
  15. 15.
    Cookson WO, Ubhi B, Lawrence R, Abecasis GR, Whalley AJ, Cox HE, et al. (2001) Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 27:372–373PubMedCrossRefGoogle Scholar
  16. 16.
    Darsow U, Vieluf D, Ring J for the APT Study Group (1999) Evaluating the relevance of aeroallergen sensitization in atopic eczema with the atopy patch test: a randomized, double-blind multicenter study. J Am Acad Dermatol 40:187–193PubMedCrossRefGoogle Scholar
  17. 17.
    Darsow U, Drzezga A, Frisch M, Munz F, Weilke F, Bartenstein P, Schwaiger M, Ring J (2000) Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions. J Invest Dermatol 115:1029–1033PubMedCrossRefGoogle Scholar
  18. 18.
    Fartasch M, Abeck D, Werfel T, Diepgen T, Schmid-Ott G, Ring J, Gieler U (2000) Aktueller Stand des interdisziplinären Modellprojektes “Neurodermitis-Schulung für Kinder und Jugendliche”. Hautarzt 51:299–301PubMedCrossRefGoogle Scholar
  19. 19.
    Giustizieri ML, Mascia F, Frezzolini A, De Pita O, Chinni LM, Gianetti A, Girolomoni G, Pastore S (2001) Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 107:871–877PubMedCrossRefGoogle Scholar
  20. 20.
    Hanifin JM (1982) Atopic dermatitis. J Am Acad Dermatol 8:1–13CrossRefGoogle Scholar
  21. 21.
    Hanifin JM, Rajka G (1980) Diagnostic features of atopic dermatitis. Acta Derm Venereol 114:146–148Google Scholar
  22. 22.
    Herzberg J (1973) Wenig bekannte Formen der Neurodermitis. Hautarzt 24:407–501Google Scholar
  23. 23.
    Imokawa G (2001) Lipid abnormalities in atopic dermatitis. J Am Acad Dermatol 45:S29–32PubMedCrossRefGoogle Scholar
  24. 24.
    Jakob T (2002) Mechanismen der Aktivierung und Mobilisation dentritischer Zellen in der Haut. Habilitationsschrift, Technische Universität MünchenGoogle Scholar
  25. 25.
    Jung T (2002) Zytokindysregulation bei atopischer Dermatitis. Dustri, MunichGoogle Scholar
  26. 26.
    Kissling S, Wüthrich B (1994) Dermatitis in young adults: personal follow-up 20 years after diagnosis in childhood. Hautarzt 45:368–371PubMedCrossRefGoogle Scholar
  27. 27.
    Korting GW (1954) Zur Pathogenese des endogenen Eczemas. Thieme, StuttgartGoogle Scholar
  28. 28.
    Kowalzick L, Kleinheinz A, Weichenthal M, Neuber K, Köhler I, et al. (1995) Low dose versus medium dose UVA1 treatment in severe atopic eczema. Acta Derm Venereol 75:43–45PubMedGoogle Scholar
  29. 29.
    Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schöpf E (1993) Highdose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 26:225–230CrossRefGoogle Scholar
  30. 30.
    Kunz B, Ring J (1999) Clinic diagnostic features of atopic eczema. In: Oranje A, et al. (ed) Pediatric dermatology, vol 2. Blackwell, OxfordGoogle Scholar
  31. 31.
    Lee Y-A, Wahn U, Kehrt R, Tarani L, Businco L, Gustafsson D, Andersson F, Oranje AP, Wolkertstorfer A, Berg A v, Hoffmann U, Küster W, Wienke T, Rüschendorf F, Reis A (2000) A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nature Genetics 26:470PubMedCrossRefGoogle Scholar
  32. 32.
    Leung DYM (2001) Atopic dermatitis and the immune system: The role of superantigens and bacteria. J Am Acad Dermatol 45:S13–16PubMedCrossRefGoogle Scholar
  33. 33.
    Leutgeb C, Bandmann HJ, Breit R (1972) Handlinienmuster, ichthyosis vulgaris und dermatitis atopica. Arch Derm Forsch 244:244–354CrossRefGoogle Scholar
  34. 34.
    Neuber K (2002) Atopisches Eczema und Staphylococcus aureus. Dustri, MunichGoogle Scholar
  35. 35.
    Olesen AB (2001) Role of the early environment for expression of atopic dermatitis. J Am Acad Dermatol 45:37–40CrossRefGoogle Scholar
  36. 36.
    Oranje AP (2000) Atopic dermatitis (AD): Evaluation and therapy. Pediatr Dermatol 17:75–83CrossRefGoogle Scholar
  37. 37.
    Platts-Mills TAE, Mitchell EB, Rowntree S, Chapman MD, Wilkins SR (1983) The role of dust mite allergens in atopic dermatitis. Clin Exp Dermatol 8:233–247PubMedCrossRefGoogle Scholar
  38. 38.
    Przybilla B, Ring J, Enders F, Winkelmann H (1991) Stigmata of atopic constitution in patients with atopic eczema or atopic respiratory disease. Acta Derm Venereol 71:407–410PubMedGoogle Scholar
  39. 39.
    Przybilla B, Eberlein-König B, Rueff F (1994) Practical management of atopic eczema. Lancet 343:1342–1346PubMedCrossRefGoogle Scholar
  40. 40.
    Rajka G (1989) Essential aspects of atopic dermatitis. Springer, Berlin Heidelberg New YorkGoogle Scholar
  41. 41.
    Reitamo S, Rissanen J, Remitz A, Granlund H, Erkko P, Elg P, Autio P, Lauerma A (1998) Tacrolismus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 111:396–398PubMedCrossRefGoogle Scholar
  42. 42.
    Ring J (1979) Atopic dermatitis: a disease of general vasoactive mediator dysregulation. Int Arch Allergy Appl Immunol 59:233–239PubMedCrossRefGoogle Scholar
  43. 43.
    Ring J (1991) Atopy: condition, disease, or syndrome? In: Ruzicka T, Ring J, Przybilla B (eds) Handbook of atopic eczema. Springer, Berlin Heidelberg New York, pp 3–8Google Scholar
  44. 44.
    Ring J, Bieber T, Vieluf D, et al. (1991) Atopic eczema. Langerhans cells and allergy. Int Arch Allergy Appl Immunol 94:194–201PubMedCrossRefGoogle Scholar
  45. 45.
    Ring J, Schröpl F (1985) Das atopische Eczema. Medizinisches Hörspiel, Frankfurt (Audio-Kassette mit Begleitheft)Google Scholar
  46. 46.
    Ring J, Kunz B, Bieber T, Vieluf D, Przybilla B (1989) The “atopy patch test” with aeroallergens in atopic eczema. J Allerg Clin Immunol 82:195Google Scholar
  47. 47.
    Ring J, Brockow K, Abeck D (1996) The therapeutic concept of “patient management” in atopic eczema. Allergy 51:206–215PubMedGoogle Scholar
  48. 48.
    Ring J (ed) (1998) Neurodermitis. Ecomed, LandsbergGoogle Scholar
  49. 49.
    Ruzicka T, Ring J, Przybilla B (eds) (1991) Handbook of atopic eczema. Springer, Berlin Heidelberg New YorkGoogle Scholar
  50. 50.
    Saurat J-H (1985) Eczema in primary immune-deficiencies. Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome. Acta Derm Venereol (Stockh) 114:125–128Google Scholar
  51. 51.
    Schäfer T, Krämer U Vieluf D, Abeck D, Behrendt H, Ring J (2000) The excess of atopic eczema in East Germany is related to the intrinsic type. Br J Dermatol 143:992–998PubMedCrossRefGoogle Scholar
  52. 52.
    Schnyder UW (1960) Neurodermitis, Asthma, Rhinitis, eine genetisch allergologische Studie. Karger, BaselGoogle Scholar
  53. 53.
    Schöpf E, Kapp A, Kim CW (1978) T-cell function in atopic dermatitis. Controlled examination of concanavalin A. Dose-response relations in cultured lymphocytes. Arch Dermatol Res 262:37–44PubMedCrossRefGoogle Scholar
  54. 54.
    Schultz-Larsen F (1985) Atopic dermatitis. Etiological studies based on a twin population. Laegeforeningens, CopenhagenGoogle Scholar
  55. 55.
    Stingl G (2001) IgE-mediated, Fcε RI-dependent allergen presentation: A pathogenic factor in atopic dermatitis? J Am Acad Dermatol 45:S517–S520CrossRefGoogle Scholar
  56. 56.
    Taieb A (1999) Hypothesis: from epidermal barrier dysfunction to atopic disorders. Contact Dermatitis 41:177–180PubMedCrossRefGoogle Scholar
  57. 57.
    Thestrup-Pedersen K, Ring J (1999) Atopic dermatitis: summary of the 1st Georg Rajka Symposium 1998 and a literature review. Acta Derm Venerol 79:257–264PubMedCrossRefGoogle Scholar
  58. 58.
    Trautmann A, Akdis M, Kleemann D, Altznauer F, Simon HU, Graeve T, Noll M, Brocker EB, Blase K, Akdis CA (2000) T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 106:25–35PubMedCrossRefGoogle Scholar
  59. 59.
    Uehara M (1985) Clinical and histological features of dry skin in atopic dermatitis. Acta Derm Venereol (Stockh) [Suppl] 114:8246Google Scholar
  60. 60.
    Valenta R, Seiberler S, Natter S, Mahler V, Mossabeb R, Ring J, Stingl G (2000) Autoallergy: A pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol 105:432–437PubMedCrossRefGoogle Scholar
  61. 61.
    Wahlgren CF, Scheynius A, Hagermark O (1990) Antipruritic effect of oral cyclosporin A in atopic dermatitis. Acta Derm Venereol 70:323–329PubMedGoogle Scholar
  62. 62.
    Wakim M, Alazard M, Yajima A, Speights D, Saxon A, Stiehm E (1998) High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol 81:153–158PubMedCrossRefGoogle Scholar
  63. 63.
    Werfel T (2000) Allergenspezifische T-Zell-Antwort bei Eczemakrankheiten. Dustri, MunichGoogle Scholar
  64. 64.
    Williams HC (ed) (2000) Atopic dermatitis. The epidemiology, causes and prevention of atopic eczema. Cambridge University Press, CambridgeGoogle Scholar
  65. 65.
    Wise F, Sulzberger MB (1933) Footnote on problem of eczema, neurodermatitis and lichenification. In: Wise F, Sulzberger MB (eds) The 1933 Year book of dermatology and syphilology. Year Book Publishers, Chicago, pp 38–39Google Scholar
  66. 66.
    Wollenberg A, Wen S, Bieber T (1999) Phenotyping of epidermal dendritic cells — clinical applications of a flow cytometric micromethod. Cytometry 37:147–155PubMedCrossRefGoogle Scholar
  67. 67.
    Wright S, Burton JL (1982) Oral-evening-primrose-seed oil improves atopic eczema. Lancet 2:1120–1122PubMedCrossRefGoogle Scholar
  68. 68.
    Wüthrich B (1975) Zur Immunpathologie der Neurodermitis constitutionalis. Huber, BernGoogle Scholar
  69. 69.
    Wüthrich B (ed) (1999) The atopic syndrome in the third millennium. Karger, BaselGoogle Scholar
  70. 70.
    Zachariae H, Cramers M, Herlin T, Jensen J, Kragballe K, Ternowitz T, Thestrup-Pedersen K (1985) Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis. Acta Derm Venereol (Stockh) [Suppl] 114:48–54Google Scholar
  71. 71.
    Stalder R, Taieb A, et al. (1993) Consensus Report of the European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCO-RAD index. Dermatology 186:23–31CrossRefGoogle Scholar

References

  1. 1.
    Alpermann HG, Sandow J, Vogel HG (1982) Tierexperimentelle Untersuchungen zur topischen und systemischen Wirksamkeit von Prednisolon-17-ethylcarbonat-21-propionat. Arzneimittelfor-schung/Drug Res 32:633Google Scholar
  2. 2.
    Barnes PJ, Adcock I (1993) Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 14:436–440PubMedCrossRefGoogle Scholar
  3. 3.
    Braun-Falco O, Ring J (1984) Zur Therapie des atopischen Ekzems. Hautarzt 35:447–454PubMedGoogle Scholar
  4. 4.
    Carnuccui R, di Rosa M, Guerrasio B, Iuvone T, Sautebin L (1987) Vasocortin: a new glucocorticoid-induced anti-inflammatory protein. Br J Pharmacol 90:443–445Google Scholar
  5. 5.
    Claman WN (1984) Antiinflammatory effects of corticosteroids Immunol. Allergy Practice 4:317–329Google Scholar
  6. 6.
    Clark CR (1985) Intracellular localisation of steroid receptors. In: Sluyser M (ed) Interaction of steroid hormone receptors with DNA. Ellis Horwood, Chichester, pp 7–56Google Scholar
  7. 7.
    Flower RJ, Rothwell NJ (1994) Lipocortin-I: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 15:71–76PubMedCrossRefGoogle Scholar
  8. 8.
    Guin JD (1984) Contact sensitivity to topical corticosteroids. J Am Acad Dermatol 10:773–782PubMedCrossRefGoogle Scholar
  9. 9.
    Hatz H (1998) Kortison und Kortikoide. Deutscher Apothekerverlag, StuttgartGoogle Scholar
  10. 10.
    Hornstein OP, Nürnberg E (eds) (1985) Externe Therapie von Hautkrankheiten. Pharmazeutische und medizinische Praxis. Thieme, StuttgartGoogle Scholar
  11. 11.
    Kaiser H (1977) Cortisonderivate in Klinik und Praxis. Thieme, StuttgartGoogle Scholar
  12. 12.
    Kligman AM (1986) Topical steroids: Perspectives and retrospectives. In: Ring J, Burg G (eds) New trends in allergy. II. Springer, Berlin Heidelberg New York, pp 342–352Google Scholar
  13. 13.
    Lubach D, Kietzmann M (1992) Dermatokortikoide — Pharmakologie und Therapie. In: Marghescu S, Wolff HH, Zaun H (eds) Kohlhammer, FreiburgGoogle Scholar
  14. 14.
    Maibach H, Stougthon RB (1973) Topical corticosteroids. Med Clin N Am 57:1253PubMedGoogle Scholar
  15. 15.
    Marghescu S (1983) Externe Kortikoidtherapie: Kontinuierliche versus diskontinuierliche Anwendung. Hautarzt 34:114–117PubMedGoogle Scholar
  16. 16.
    Miyachi Y (1982) Adrenal axis suppression caused by a small dose of a potent topical corticosteroid. Arch Dermatol 118:451PubMedCrossRefGoogle Scholar
  17. 17.
    Niedner R, Ziegenmeyer J (eds) (1992) Dermatika — Therapeutischer Einsatz, Pharmakologie und Pharmazie. Wiss Verlagsgesellsch, StuttgartGoogle Scholar
  18. 18.
    Poulsen J, Rorsman H (1980) Ranking of glucocorticoid creams and ointments. Acta Derm Venereol 60:57PubMedGoogle Scholar
  19. 19.
    Ponec M, Kempanaar SA, DeKloet ER (1981) Corticosteroids and cultured human epidermal keratinocytes. J Invest Dermatol 76:211–214PubMedCrossRefGoogle Scholar
  20. 20.
    Przybilla B, Ring J (1983) Äußerliche Behandlung mit Glukokortikosteroiden. Med Monatsschr Pharm 6:192–205Google Scholar
  21. 21.
    Ring J, Fröhlich HH (1985) Wirkstoffe in der dermatologischen Therapie, 2nd edn. Springer, Berlin Heidelberg New YorkGoogle Scholar
  22. 22.
    Schaefer H, Zesch A, Schalla W, Stüttgen G (1980) Pharmakokinetik externer Glucocorticoide. Allergologie 3:194Google Scholar
  23. 23.
    Schell H, Hornstein OP (1980) Endogener Kortisolrhythmus und Epidermisproliferation. Akt Derm 6:27–33Google Scholar
  24. 24.
    Schleimer RP (1993) An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 45[Suppl]:1Google Scholar
  25. 25.
    Schmutzler W (1999) Antiallergische und antientzündliche Pharmakotherapie. In: Heppt W, Renz H, Röcken M (eds) Allergologie. Springer, Berlin Heidelberg New York, pp 160–174Google Scholar
  26. 26.
    Schöpf E(1972) Nebenwirkungen externer Corticoidtherapie. Hautarzt 23:295Google Scholar
  27. 27.
    Schöpf E (1980) Kortikosteroide in der Dermatologie. Allergologie 3:306Google Scholar
  28. 28.
    Sulzberger MB, Witten VH (1952) The effect of topically applied compound F in selected dermatoses. J Invest Dermatol 19:101PubMedCrossRefGoogle Scholar
  29. 29.
    Wendt H, Frosch PJ (1982) Klinisch-pharmakologische Modelle zur Prüfung von Corticoidexterna. Karger, BaselGoogle Scholar
  30. 30.
    Wilckens T (1995) Glucocorticoids and immune function: hormonal dysfunction. Trends Pharmacol Sci 16:193–197PubMedCrossRefGoogle Scholar

References

  1. 1.
    Bergner T, Przybilla B (1992) Photosensitization caused by ibuprofen. J Am Acad Dermatol 26:114–116PubMedCrossRefGoogle Scholar
  2. 2.
    Breit R (1987) Rötung und Bräunung der Haut durch UVA. Zuckschnverdt, MunichGoogle Scholar
  3. 3.
    Eberlein-König B, Fesq H, Abeck D, Przybilla B, Placzek M, Ring J (2000) Systemic vitamin C and vitamin E do not prevent photoprovocation test reactions in polymorphous light eruption. Photodermatol Photoimmunol Photomed 16:50–52PubMedCrossRefGoogle Scholar
  4. 4.
    Epstein S (1939) Photoallergy and primary photosensitivity to sulfanilamide. J Invest Dermatol 2:43–51CrossRefGoogle Scholar
  5. 5.
    Ferguson J, Johnson BE (1993) Clinical and laboratory studies of the photosensitizing potential of norfloxacin, a 4-quinolone broad-spectrum antibiotic. Br J Dermatol 128:185–195CrossRefGoogle Scholar
  6. 6.
    Fjellner B (1981) Experimental and clinical pruritus. Studies on some putative peripheral mediators. The influence of ultraviolet light and transcutaneous nerve stimulation. Thesis, StockholmGoogle Scholar
  7. 7.
    Fotiades J, Soter NA, Lim HW (1995) Results of evaluation of 203 patients for photosensitivity in a 7.3-year period. J Am Acad Dermatol 33:597–602PubMedCrossRefGoogle Scholar
  8. 8.
    Frain-Bell W (1986) Cutaneous photobiology. Oxford University Press, New YorkGoogle Scholar
  9. 9.
    Galosi A, Przybilla B, Ring J, Dorn M (1984) Systemische Photoprovokation mit Surgam. Allergologie 7:143–144Google Scholar
  10. 10.
    Gigli I, Lim HW (1981) Release of proinflammatory peptides by complement in porphyrin-induced photosensitivity. In: Ring J, Burg G (eds) New trends in allergy. Springer, Berlin Heidelberg New York, p 5848Google Scholar
  11. 11.
    Gollhausen R, Przybilla B, Galosi A, Köhler K, Ring J (1987) Environmental influences of UVB erythema. Photodermatology 4:148–153PubMedGoogle Scholar
  12. 12.
    Hasei K, Ichihashi M (1982) Solar urticaria. Determinations of action and inhibition spectra. Arch Dermatol 118:346–350PubMedCrossRefGoogle Scholar
  13. 13.
    Hölzle E, Plewig G, Kries R v, Lehmann P (1987) Polymorphous light eruption. J Invest Dermatol 88:32–38CrossRefGoogle Scholar
  14. 14.
    Hölzle E, Neumann N, Hausen B, Przybilla B, Schauder S, Hönigsmann H, Bircher A, Plewig G (1991) Photopatch testing: The 5-year experience of the German, Austrian and Swiss photopatch test group. J Am Acad Dermatol 25:59–68PubMedCrossRefGoogle Scholar
  15. 15.
    Hönigsmann H, Stingl G (eds) (1986) Therapeutic photomedicine. Karger, BaselGoogle Scholar
  16. 16.
    Horio T (1975) Chlorpromazine photoallergy. Arch Dermatol 111:1469–1471PubMedCrossRefGoogle Scholar
  17. 17.
    Ippen H (1973) Photochemie der Haut. In: Herrmann F, Oppen H, Schaefer H, Stüttgen G (eds) Biochemie der Haut. Thieme, Stuttgart, p 146Google Scholar
  18. 18.
    Jitsukawa K, Suizu R, Hidano A (1984) Chlorella photosensitization, a new phytophotodermatosis. Int J Dermatol 23:263PubMedCrossRefGoogle Scholar
  19. 19.
    Jung EG (1981) Die belichtete Epikutantestung. Akt Derm 7:163–165Google Scholar
  20. 20.
    Jung EG, Hardmeier T (1967) Zur Histologie der photoallergischen Testreaktion. Dermatologica 135:243–252PubMedCrossRefGoogle Scholar
  21. 21.
    Kavli G, Volden G (1984) Phytophotodermatitis. Photodermatology 1:65–75PubMedGoogle Scholar
  22. 22.
    Kripke ML (1986) Photoimmunology, the first decade. Curr Probl Dermatol 15:164–175PubMedGoogle Scholar
  23. 23.
    Lehmann P (1990) Die Deutschsprachige Arbeitsgemeinschaft Photopatch-Test (DAPT). Haut-arzt 41:295–297Google Scholar
  24. 24.
    Lischka G, Jung EG (1982) Lichtkrankheiten der Haut, 2nd edn. Perimed, ErlangenGoogle Scholar
  25. 25.
    Ljunggren B, Bjellerup M (1986) Systemic drug photosensitivity. Photodermatology 3:26–35PubMedGoogle Scholar
  26. 26.
    Ljunggren B (1990) Severe phototoxic burn following celery ingestion. Arch Dermatol 126:1334–1336PubMedCrossRefGoogle Scholar
  27. 27.
    Maurer T (1983) Contact and photocontact allergens. A manual of predictive test methods. Dekker, New YorkGoogle Scholar
  28. 28.
    Plewig G, Hölzle E, Roser-Maaß E, Hofmann C (1985) Photoallergy. In: Ring J, Burg G (eds) New trends in allergy. Springer, Berlin Heidelberg New York, pp 152–169Google Scholar
  29. 29.
    Przybilla B, Ring J, Schwab U, Galosi A, Dorn M, Braun-Falco O (1987) Photosensibilisierende Eigenschaften nicht-steroidaler Antirheumatika im Photopatch-Test. Hautarzt 38:18–25PubMedGoogle Scholar
  30. 30.
    Przybilla B (1987) Phototestungen bei Lichtdermatosen. Hautarzt 38:S23–S28Google Scholar
  31. 31.
    Przybilla B, Schwab-Przybilla U, Ruzicka T, Ring J (1987) Phototoxicity of non-steroidal antiinflammatory drugs demonstrated in vitro by a photobasophil-histamine-release test. Photodermatology 4:73–78PubMedGoogle Scholar
  32. 32.
    Przybilla B, Ring J, Eberlein B (1988) Inhibition of in vitro basophil histamine release by UVA irradiation. J Allergy Clin Immunol 83:302CrossRefGoogle Scholar
  33. 33.
    Przybilla B, Bergner T (1992) Diagnostik von lichtallergischen Exanthemen im erscheinungsfreien Intervall. Hautarzt 43:100–101PubMedGoogle Scholar
  34. 34.
    Przybilla B, Eberlein-König B (2000) Photoprovokationstests. In: Przybilla B, Bergmann K, Ring J (eds) Praktische allergologische Diagnostik. Steinkopff, DarmstadtGoogle Scholar
  35. 35.
    Ring J, Przybilla B, Ruzicka T (1987) Nonsteroidal antiinflammatory drugs induce UV-dependent histamine and leukotriene release from peripheral human leukocytes. Int Arch Allergy Appl Immunol 82:344–346PubMedCrossRefGoogle Scholar
  36. 36.
    Ring J, Przybilla B (1990) UV irradiation and allergy. Allergologie 12 (Suppl EAACI):75–79Google Scholar
  37. 37.
    Ruzicka T, Walter JF, Printz MP (1983) Changes in arachidonic acid metabolism in ultraviolet irradiated hairless mouse skin. J Invest Dermatol 81:300–303PubMedCrossRefGoogle Scholar
  38. 38.
    Schauder S, Ippen H (1986) Photoallergic and allergic contact dermatitis from dibenzoylmethanes. Photodermatology 3:140–147PubMedGoogle Scholar
  39. 39.
    Schauder S, Schrader A, Ippen H (1996) Göttinger Liste 1996. Sonnenschutzkosmetik in Deutschland, 4th edn. Blackwell, BerlinGoogle Scholar
  40. 40.
    Schmidt T, Abeck D, Ring J (1998) Photoallergic contact dermatitis due to combined UVB-(4-methylbenzylidene camphor/octyl methoxy-cinnamate) and UVA-(benzophenone-3/butyl-methoxy-dibenzoylmethane) absorber. Dermatology 196:354–357PubMedCrossRefGoogle Scholar
  41. 41.
    Schulz KH, Wiskemann K, Wolf K (1956) Klinische und experimentelle Untersuchungen über die photodynamische Wirksamkeit von Phenotiazinderivaten, insbesondere Megaphen. Arch Klin Exp Dermatol 202:285–298PubMedCrossRefGoogle Scholar
  42. 42.
    Terui T, Okuyama R, Tagami H (2001) Molecular events occurring behind ultraviolet-induced skin inflammation. Curr Opin Allergy Clin Immunol 1:461–467PubMedCrossRefGoogle Scholar
  43. 43.
    Wessner D, Hofmann H, Ring J (1999) Phytopho-todermatitis due to Ruta graveolens applied as protection against evil spells. Contact Dermatitis 41:232–233PubMedCrossRefGoogle Scholar
  44. 44.
    Wucherpfennig V (1931) Biologie und praktische Verwendbarkeit der Erythemschwelle des UV. Strahlentherapie 40:201–243Google Scholar

References

  1. 1.
    Aberer W, Kränke B (1997) Überempfindlichkeitsreaktionen auf Impfstoffe. Allergologie 20:407–411Google Scholar
  2. 2.
    Adkinson NF (1998) Drug allergy. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW (eds) Allergy: principles and practice. CV Mosby, St. Louis, pp 1212–1224Google Scholar
  3. 3.
    Baldo BA (2000) Diagnosis of allergy to penicillins and cephalosporins. Structural and immunochemical considerations. Allergy Clin Immunol Int 12:206–212CrossRefGoogle Scholar
  4. 4.
    Bates DW, Cullen DJ, Laird N, et al. (1995) Incidence of adverse drug events and potential adverse drug events. JAMA 274:29–34PubMedCrossRefGoogle Scholar
  5. 5.
    Berg PA, Daniel PT, Brattig N (1987) Immunologie und Nachweis medikamentöser Allergien. In: Fuchs E, Schulz KH (eds) Manuale allergologicum IV, 11. Dustri, München-Deisenhofen, 1–13Google Scholar
  6. 6.
    Bircher AJ (1996) Arzneimittelallergie und Haut. Thieme, StuttgartGoogle Scholar
  7. 7.
    Bircher AJ (2001) Hyposensibilisierung bei Arzneimittelallergie. In: Ring J, Darsow U (eds) Allergie 2000. Dustri, München-Deisenhofen, 219–228Google Scholar
  8. 8.
    Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P (2002) General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 57:45–51PubMedCrossRefGoogle Scholar
  9. 9.
    Classen DC, Pestotnik SL, Evans RS, Burke JP (1991) Computerized surveillance of adverse drug events in hospital patients. JAMA 266: 2847–2851PubMedCrossRefGoogle Scholar
  10. 10.
    Coleman JW, Blanca M (1998) Mechanisms of drug allergy. Immunol Today 19:196–198PubMedCrossRefGoogle Scholar
  11. 11.
    Demoly P, Bousquet J (2001) Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol 1:305–310PubMedCrossRefGoogle Scholar
  12. 12.
    Demoly P, et al. (2004) Provocative testing. Allergy (in press)Google Scholar
  13. 13.
    DeShazo RD, Kemp SF (1997) Allergic reactions to drugs and biologic agents. JAMA 278:1895–1906PubMedCrossRefGoogle Scholar
  14. 14.
    Dogliotti M (1968) An instance of fatal reaction to the penicillin scratch test. Dermatologica 136: 489–496PubMedCrossRefGoogle Scholar
  15. 15.
    Eapen SS, Connor EL, Gern JE (2000) Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old child. Ann Allergy Asthma Immunol 85:395–397PubMedCrossRefGoogle Scholar
  16. 16.
    Eichler G, Merk HF (1997) Unerwünschte Arzneimittelreaktionen durch Antibiotika. Allergologie 20:368–374Google Scholar
  17. 17.
    Fam AG, Dunne SM, Iazzetta J, Paton TW (2001) Efficacy and safety of desensitization to allopurinol following cutaneous reactions. Arthritis Rheum 44:231–238PubMedCrossRefGoogle Scholar
  18. 18.
    Federlin K (1974) Insulinallergie. Dtsch Med Wochenschr 99:535–537PubMedCrossRefGoogle Scholar
  19. 19.
    Fisher MM, Baldo BA (2000) Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intens Care 28:167–170Google Scholar
  20. 20.
    Gadde J, Spence M. Wheeler B, Adkinson NF (1993) Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 270:2456–2463PubMedCrossRefGoogle Scholar
  21. 21.
    Gall H, Merk H, Scherb W, Sterry W (1994) Anticonvulsiva-Hypersensitivitätssyndrom auf Carbamazepin. Hautarzt 45:494–498PubMedCrossRefGoogle Scholar
  22. 22.
    Hedin H, Richter W, Ring J (1976) Dextran-induced anaphylactoid reactions in man: role of dextran reactive antibodies. Int Arch Allergy Appl Immunol 52:145–152PubMedCrossRefGoogle Scholar
  23. 23.
    Hoigné R (1965) Arzneimittel-Allergien. Klinische und serologisch-experimentelle Untersuchungen. Huber, BernGoogle Scholar
  24. 24.
    Hoigné R, Schlumberger HP, Vervloet D, Zoppi M (1993) Epidemiology of allergic drug reactions. In: Burr ML (ed) Epidemiology of clinical allergy. Monogr Allergy 31. Karger, Basel, 147–170Google Scholar
  25. 25.
    Jäger L, Merk HF (1996) Arzneimittel-Allergie. Gustav Fischer, JenaGoogle Scholar
  26. 26.
    Karch FE, Lasagna L (1975) Adverse drug reactions. A critical review. JAMA 234:1236–1241PubMedCrossRefGoogle Scholar
  27. 27.
    Kelkar PS, Li JT-C (2001) Cephalosporin allergy. N Engl J Med 345:804–811PubMedCrossRefGoogle Scholar
  28. 28.
    Kleinhans D (1985) Reaktionen vom Soforttyp auf Analgetika-Wirkstoffe. Allergie und Intoleranz. Allergologie 8:254–259Google Scholar
  29. 29.
    Kraft D, Wide L (1976) Clinical patterns and results of radioallergosorbent test (RAST) and skin tests in penicillin allergy. Br J Dermatol 94: 593–601PubMedCrossRefGoogle Scholar
  30. 30.
    Lasagna L (1986) The placebo effect. J Allergy Clin Immunol 78:161–165PubMedCrossRefGoogle Scholar
  31. 31.
    Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 279:1200–1205PubMedCrossRefGoogle Scholar
  32. 32.
    Maucher OM, Fuchs A (1983) Kontakturtikaria im Epikutantest bei Pyrazolonallergie. Hautarzt 34:383–386PubMedGoogle Scholar
  33. 33.
    Menzel SH, Vente C, Fuchs T (1997) Heparin-Allergie. Allergo J 6:372–376Google Scholar
  34. 34.
    Merk H (1989) Arzneimittelallergie: Einfluß des Fremdstoff-Metabolismus. Allergologie 12:171–173Google Scholar
  35. 35.
    Merk HF (1998) Skin metabolism. In: Lepoittevin JP, Basketter DA, Goossens KA, Karlberg AT (eds) Allergic contact dermatitis. Springer, Berlin Heidelberg New York, pp 68–80Google Scholar
  36. 36.
    Moneret-Vautrin D, Laxenaire MC (1993) The risk of allergy related to general anaesthesia. Clin Exp Allergy 23:629–633PubMedCrossRefGoogle Scholar
  37. 37.
    O’Donnell BF, Tan CY (1993) Delayed hypersensitivity reaction to heparin. Br J Dermatol 129: 634–636PubMedCrossRefGoogle Scholar
  38. 38.
    Pallela FJ, Delaney KM, Moorman AC, et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338:853–860CrossRefGoogle Scholar
  39. 39.
    Parker CW (1975) Drug allergy. N Engl J Med 292:511–521PubMedGoogle Scholar
  40. 40.
    Pichler WJ (1993) Diagnostische Möglichkeiten bei Medikamentenallergien. Schweiz Med Wochenschr 123:1183–1192PubMedGoogle Scholar
  41. 41.
    Pichler WJ, Yawalkar N (2000) Allergic reactions to drugs: involvement of T cells. Thorax 55[Suppl 2]:S61–S65PubMedCrossRefGoogle Scholar
  42. 42.
    Pouyanne P, Haramburu F, Imbs JL, Bégaud B (2000) Admissions to hospital caused by adverse drug reactions: cross incidence study. Br Med J 320:1036CrossRefGoogle Scholar
  43. 43.
    Przybilla B, Bonnländer AR, Ring J (1986) Anaphylactoid reactions to mild analgesics. In: Ring J, Burg G (eds) New trends in allergy. II. Springer, Berlin Heidelberg New York, pp 262–271Google Scholar
  44. 44.
    Przybilla B, Fuchs T, Ippen H, et al. (1991) Empfehlungen für die Aufklärung von Überempfindlichkeitsreaktionen auf Arzneimittel. Allergologie 14:58–60Google Scholar
  45. 45.
    Reilly TP, Lash LH, Dollo MA, et al. (2000) A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J Invest Dermatol 114:1164–1173PubMedCrossRefGoogle Scholar
  46. 46.
    Ring J (1978) Anaphylaktoide Reaktionen nach Infusion natürlicher und künstlicher Kolloide. Springer, Berlin Heidelberg New YorGoogle Scholar
  47. 47.
    Ring J (1986) Exacerbation of eczema by formalin-containing hepatitis B vaccine in a formaldehyde-allergic patient. Lancet 2:522–523PubMedCrossRefGoogle Scholar
  48. 48.
    Ring J (1987) Diagnostik von Arzneimittel-bedingten Unverträglichkeiten. Hautarzt 38:516–522Google Scholar
  49. 49.
    Schaub N, Bircher AJ (2000) Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro. Allergy 55:191–193PubMedCrossRefGoogle Scholar
  50. 50.
    Schnyder B, Pichler WJ (2000) Skin laboratory tests in amoxicillin-and penicillin-induced morbilliform skin eruption. Clin Exp Allergy 30: 590–595PubMedCrossRefGoogle Scholar
  51. 51.
    Schulz KH, Kasemir HD (1990) Arzneimittelallergie. In: Fuchs E, Schulz KH (eds) Manuale allergologicum, vol 3. Dustri, München-Deisenhofen, 1–71Google Scholar
  52. 52.
    Solensky R, Earl HS, Gruchalla RS (2000) Clinical approach to penicillin-allergic patients: a survey. Ann Allergy Asthma Immunol 84:329–333PubMedCrossRefGoogle Scholar
  53. 53.
    Stejskal VDM, Olin RG, Forsbeck M (1986) The lymphocyte transformation test for diagnosis of drug-induced occupational allergy. J Allergy Clin Immunol 77:411–426PubMedCrossRefGoogle Scholar
  54. 54.
    Sullivan TJ (1982) Antigen-specific desensitization of patients allergic to penicillin. J Allergy Clin Immunol 69:500–508PubMedCrossRefGoogle Scholar
  55. 55.
    Templeton B (1965) Suicide by anaphylaxis attempted with penicillin. JAMA 192:264PubMedGoogle Scholar
  56. 56.
    Van Arsdel PP Jr (1982) Allergy and adverse drug reactions. J Am Acad Derm 6:833–845CrossRefGoogle Scholar
  57. 57.
    Velcovsky H-G, Federlin K (1987) Unverträglichkeitsreaktionen gegenüber Insulin, auch Human-insulin, bei Diabetikern. Allergologie 10:287–296Google Scholar
  58. 58.
    Vervloet D, Durham S (1998) Adverse reactions to drugs. Br Med J 316:1511–1514Google Scholar
  59. 59.
    Vieluf D (2000) Arzneimittelreaktionen. In: Przybilla B, Bergmann K, Ring J (eds) Praktische allergologische Diagnostik. Steinkopff, Darmstadt, pp 224–242Google Scholar
  60. 60.
    Vieluf D, Ring J (2001) Der Allergie-Paß. MMW Fortschr Med 143:608–610Google Scholar
  61. 61.
    Vittorio CC, Muglia JJ (1995) Anticonvulsant hypersensitivity syndrome. Arch Intern Med 155:2285–2290PubMedCrossRefGoogle Scholar
  62. 62.
    De Weck AL, Bundgaard M (eds) (1984) Allergic reactions to drugs. Handbook of experimental pharmacology, vol 63. Springer, Berlin Heidelberg New YorkGoogle Scholar
  63. 63.
    De Weck AL (1997) Zellulärer Allergen-Stimulie-rungstest (CAST). Allergologie 20:487–502Google Scholar
  64. 64.
    Weiss ME, Adkinson NF (1991) Allergy to protamine. Clin Rev Allergy 9:339–355PubMedGoogle Scholar
  65. 65.
    Zanni MP, von Greyerz S, Schnyder B, et al. (1998) HLA-restricted, processing-and metabolism-independent pathway of drug recognition by human ab T lymphocytes. J Clin Invest 102:1591–1598PubMedCrossRefGoogle Scholar

References

  1. 1.
    Brockow K, Ring J (1996) Mechanisms of pseudo-allergic reactions due to radiographic contrast media. Allergy Clin Immunol Int 8:123–125Google Scholar
  2. 2.
    Brockow K, Vieluf D, Püschel K, Grosch J, Ring J (1999) Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to non-ionic radiocontrast medium. J Allergy Clin Immunol 104:237–238PubMedCrossRefGoogle Scholar
  3. 3.
    Capron A, Ameisen J, Joseph M, Auriault C, Tarnel AB, Caen J (1985) New functions for platelets and their pathological implications. Int Arch Allergy Appl Immunol 77:107–114PubMedCrossRefGoogle Scholar
  4. 4.
    Conroy MC, de Weck AL (1981) Effect of aspirin and indomethacin on histamine release from leukocytes of patients with suspected intolerance to aspirin. Int Arch Allergy Appl Immunol 66[Suppl 1]:152–153CrossRefGoogle Scholar
  5. 5.
    Czech W, Schöpf E, Kapp A (1995) Release of sulfidoleukotrienes in vitro: Its relevance in the diagnosis of pseudoallergy to acetylsalicylic acid. Inflamm Res 44:291–295PubMedCrossRefGoogle Scholar
  6. 6.
    Dahlen B, Szczeklik A, Murray JJ (2001) Celecoxib in patients with asthma and aspirin intolerance (letter). N Engl J Med 344:142PubMedCrossRefGoogle Scholar
  7. 7.
    Denborough MA, Lovell RRH (1960) Anaesthetic deaths in a family. Lancet II:362Google Scholar
  8. 8.
    Doenicke A, Koenig UD (eds) (1983) Immunologie in Anästhesie und Intensivmedizin. Sertürner Workshops Einbek. Springer, Berlin Heidelberg New YorkGoogle Scholar
  9. 9.
    Dukor P, Kallos P, Schlumberger HD, West GB (eds) (1980) Pseudo-allergic reactions, 3 vols. Karger, BaselGoogle Scholar
  10. 10.
    Fitzgerald GA, Patrono C (2001) The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 345:433–442PubMedCrossRefGoogle Scholar
  11. 11.
    Gaetani GF, Luzatto L (1980) Haemolytic reactions induced by drugs and other agents: the role of red cell enzyme abnormalities and of abnormal haemoglobins. In: Dukor P, Kallos P, Schlumberger HD, West GB (eds) Pseudo-allergic reactions; involvement of drugs and chemicals. vol. 2, Karger, Basel, 1–19Google Scholar
  12. 12.
    Grimm V, Rakoski J, Ring J (2004) Selective COX-2 inhibitors also can elicit symptoms in patients with aspirin idiosyncrasy. J Allergy Clin Immunol (in press)Google Scholar
  13. 13.
    Hoigné R (1962) Allergische und pseudo-allergische Reaktionen auf Penicillinpräparate. Acta Allergol 17:521Google Scholar
  14. 14.
    Incaudo G, Schatz M, Patterson R, Rosenberg M, Yamamoto E, Hamburger RN (1978) Administration of local anesthetics to patients with a history of prior adverse reaction. J Allergy Clin Immunol 61:339–345PubMedCrossRefGoogle Scholar
  15. 15.
    Kallos P, Kallos L (1980) Histamine and some other mediators of pseudo-allergic reactions. In: Pseudo-allergic reactions: involvement of drugs and chemical, vol. 1. Karger, Basel, p 28Google Scholar
  16. 16.
    Kleinhans D, Galinsky T (1982) Zur möglichen Provokation eines Bronchialasthmas und einer Urtikaria durch Natriumdisulfit. Allergologie 4:120–121Google Scholar
  17. 17.
    Lasser EC, Lang JH, Lyon SG, Hamblin AE, Howard MM (1981) Prekallikrein-kallikrein conversion rate as a predictor of contrast media catastrophes. Radiology 140:11–15PubMedGoogle Scholar
  18. 18.
    Lorenz W, Doenicke A (1978) Histamine release in clinical conditions. Mt Sinai J Med N Y 45:357–386Google Scholar
  19. 19.
    Meßmer K, Lorenz W, Sunder-Plassmann L, Klövekorn WP, Hutzel M (1970) Histamine release as cause of hypotension following rapid colloid infusion. Arch Pathol Pharm 267:433–439Google Scholar
  20. 20.
    Paul E, Gall H-M, Mechlin A, Möller R, Müller I (2001) Acetylsalicylic acid (ASA)-augmentation in relation to ASA-intolerance. Allergo J 10: 269–272Google Scholar
  21. 21.
    Pierzchalska M, Mastalerz L, Sanak M, et al. (2000) A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes preludes its value for aspirin sensitivity in asthma. Clin Exp Allergy 30:1785–1791PubMedCrossRefGoogle Scholar
  22. 22.
    Przybilla B, Ring J (1987) Pseudo-allergische Arzneimittelreaktionen: Pathophysiologie und Diagnostik. Z Hautkr 62:430–443PubMedGoogle Scholar
  23. 23.
    Ring J (1978) Anaphylaktoide Reaktionen nach Infusion natürlicher und künstlicher Kolloide. Springer, Berlin Heidelberg New YorkGoogle Scholar
  24. 24.
    Ring J, Brockow K (2004) Pseudo-allergische Arzneimittelreaktionen. In: Schultze-Werninghaus G, et al. (eds) Manuale allergologicum, 2nd edn. Dustri, Munich (in press)Google Scholar
  25. 25.
    Ring J, Arroyave CM, Fritzler MJ, Tan EM (1978) In vitro histamine and serotonin release by radiographic contrast media (RCM). Complement dependent and independent release reaction and changes in ultrastructure of human blood cells. Clin Exp Immunol 32:105–118PubMedGoogle Scholar
  26. 26.
    Ring J, Rothenberger KH, Clauß W (1985) Prevention of anaphylactoid reactions after radiographic contrast media in fusion by combined histamine H1-and H2-receptor antagonists: results of a prospective controlled trial. Int Arch Allergy Appl Immunol 78:9–14PubMedCrossRefGoogle Scholar
  27. 27.
    Ring J, Walz U (1985) Indomethacin enhances in vitro histamine release induced by anti-IgE and Ca-Ionophore but inhibits C5a-induced release reactions from basophils of atopics and normals. Int Arch Allergy Appl Immunol 77:225–227PubMedCrossRefGoogle Scholar
  28. 28.
    Ring J (1992) Pseudo-allergic reactions. In: Korenblat PE, Wedner HJ (eds) Allergy: theory and practice. Saunders, Philadelphia, pp 243–264Google Scholar
  29. 29.
    Ruzicka T, Gerstmeier M, Przybilla B, Ring J (1987) Allergy to local anesthetics: comparison of patch test with prick and intradermal test results. J Am Acad Dermatol 16:1202–1208PubMedCrossRefGoogle Scholar
  30. 30.
    Samter M, Beers RF (1968) Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 68:975–983PubMedGoogle Scholar
  31. 31.
    Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F (2001) NSAID hypersensitivity in the COX-2 inhibitor era. ACI Int 13:211–218Google Scholar
  32. 32.
    Schick E, Weber L, Gall H (1996) Delayed hypersensitivity reaction to the non-ionic contrast medium iopromide. Contact Dermatitis 35:312PubMedCrossRefGoogle Scholar
  33. 33.
    Simon RA (1984) Adverse reactions to drug additives. J Allergy Clin Immunol 74:623PubMedCrossRefGoogle Scholar
  34. 34.
    Stevenson DD (1984) Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal antiinflammatory drugs. J Allergy Clin Immunol 74:617–622PubMedCrossRefGoogle Scholar
  35. 35.
    Stevenson DD, Simon RA (2001) Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 108:47–51PubMedCrossRefGoogle Scholar
  36. 36.
    Szczeklik A, Sanak M (2000) Genetic mechanisms in aspirin-induced asthma. Am J Resp Crit Care Med 161:S142–146PubMedGoogle Scholar
  37. 37.
    Szczeklik A, Nizankowska E, Sanak M, Swierczynska M (2001) Aspirin-induced rhinitis and asthma. Curr Opin Allergy Clin Immunol 1:27–33PubMedCrossRefGoogle Scholar
  38. 38.
    Till G, Rother U, Gemsa D, Gerhardt P (1977) Aktivierung des Komplementsystems bei Zwischenfällen nach Kontrastmittelinjektionen. Verh Dtsch Ges Inn Med 83:1589–1591PubMedGoogle Scholar
  39. 39.
    Vervloet DL, Dor P, Arneud A, Senft M, Alazia M, Charpin J (1985) Anaphylactic reactions to succinylcholine. Prevention of mediator release by choline. J Allergy Clin Immunol 75:150CrossRefGoogle Scholar
  40. 40.
    Virchow C (ed) (1986) Analgetika, Asthma. Medidact 6. Programmed, FrankfurtGoogle Scholar
  41. 41.
    Voigtländer V, Walter E, Siess R, Rother U (1981) Acetylsalicylic acid intolerance: a possible role of complement. Int Archs Allergy Appl Immunol 66[Suppl 1]:154–155CrossRefGoogle Scholar
  42. 42.
    Wahl R, Kleinhans D (1989) IgE-mediated allergic reactions to fruit gums and investigation of cross-reactivity between gelatine and modified gelatine-containing products. Clin Exp Allergy 19:77–80PubMedCrossRefGoogle Scholar
  43. 43.
    Wedi B, Kapp A (2000) Aspirin induced adverse skin reactions: new pathophysiological aspects. Thorax 55[Suppl 2]:S70–S71PubMedCrossRefGoogle Scholar
  44. 44.
    Wüthrich B (1983) Allergische und pseudo-allergische Reaktionen der Haut durch Arzneimittel und Lebensmitteladditiva. Schweiz Rdsch Med (Praxis) 72:691–699Google Scholar
  45. 45.
    Yoshida S, Ishizaki Y, Onuma K, Shoji T, Nakagawa H, Amayasu H (2000) Selective cyclo-oxygenase 2 inhibitor in patients with aspirin-induced asthma. J Allergy Clin Immunol 106:1203–1204CrossRefGoogle Scholar

References

  1. 1.
    Aberer W, Stingl G, Wolff K (1982) Stevens-Johnson-Syndrom und toxische epidermale Nekrolyse nach Sulfonamideinnahme. Hautarzt 33:484–490PubMedGoogle Scholar
  2. 2.
    Archard HO (1979) Stomatologic disorders of an internal and integumental nature. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds) Dermatology in general medicine. McGraw Hill, New York, p 834Google Scholar
  3. 3.
    Arndt KA, Jick H (1976) Rate of cutaneous reactions to drugs. J Am Med Assoc 235:918CrossRefGoogle Scholar
  4. 4.
    Bachot N, Roujeau J-C (2001) Physiopathology and treatment of severe drug eruptions. Curr Opin Allergy Clin Immunol 1:293–298PubMedCrossRefGoogle Scholar
  5. 5.
    Barreiro P, Soriano V, Casas E, et al. (2000) Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids. AIDS 14:2153–2157PubMedCrossRefGoogle Scholar
  6. 6.
    Behrendt H, Gollnick H, Bonnekoh B (2000) Up-regulated perforin expression of CD8+ blood lymphocytes in generalized non-anaphylactic drug eruptions and exacerbated psioriasis. Eur J Dermatol 10:365–369PubMedGoogle Scholar
  7. 7.
    Bergner T, Przybilla B, Ring J (1989) Anaphylactoid reaction to the coloring agent Erythrosine in an antiallergic drug. Allergy Clin Immunol News 1:177–179Google Scholar
  8. 8.
    Bigby M, Stern R (1985) Cutaneous reactions to nonsteroidal anti-inflammatory drugs. J Am Acad Dermatol 12:866–876PubMedCrossRefGoogle Scholar
  9. 9.
    Billingham RE, Streilein JW (1968) Toxic epidermal necrolysis and homologous disease in hamsters. Arch Dermatol 98:528PubMedCrossRefGoogle Scholar
  10. 10.
    Bork K (1985) Kutane Arzneimittelnebenwirkungen. Unerwünschte Wirkungen systemisch verabreichter Medikamente an Haut und hautnahen Schleimhüten bei Erwachsenen und Kindern. Schattauer, StuttgartGoogle Scholar
  11. 11.
    Braun-Falco O, Bandmann HJ (eds) (1970) Das Lyell-Syndrom. Das Syndrom der verbrühten Haut. Huber, BernGoogle Scholar
  12. 12.
    Braun-Falco O, Plewig G, Wolff HH (1998) Dermatologie und Venerologie, 4th edn. Springer, Berlin Heidelberg New YorkGoogle Scholar
  13. 13.
    Craven NM (2000) Management of toxic epidermal necrolysis. Hosp Med 61:778–781PubMedGoogle Scholar
  14. 14.
    Crowson AN, Magro CM (1999) Recent advances in the pathology of cutaneous drug eruptions. Dermatol Clin 17:537–560PubMedCrossRefGoogle Scholar
  15. 15.
    Davis JP, Chesney PJ, Wand PJ, LaVenture M (1980) Toxic-shock syndrome: Epidemiologic features, recurrence, risk factors and prevention. N Engl J Med 303:1429–1435PubMedCrossRefGoogle Scholar
  16. 16.
    Fellner MJ, Prutkin L (1970) Morbilliform eruptions caused by penicillin. A study by electron microscopy and immunologic tests. J Invest Dermatol 55:390–395PubMedCrossRefGoogle Scholar
  17. 17.
    French LE, Tschopp J (2000) Fas-mediated cell death in toxic epidermal necrolysis and graft-versus-host disease; potential for therapeutic inhibition. Schweiz Med Wochenschr 130:1656–1661PubMedGoogle Scholar
  18. 18.
    Goerz G, Ruzicka T (1978) Lyell-Syndrom. Grosse, BerlinGoogle Scholar
  19. 19.
    Gutierrez-Ramos JC, Lloyd C, Gonzalo JA (1999) Eotaxin from an eosinophilic chemokine to a major regulator of allergic reactions. Immunol Today 20:500–504PubMedCrossRefGoogle Scholar
  20. 20.
    Hari Y, Frutig-Schnyder K, Hurni M, Yawalkar N, Zanni MP, Schnyder B, Kappeler A, von Greyerz S, Braathen LR, Pichler WJ (2001) T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 31:1398–1408PubMedCrossRefGoogle Scholar
  21. 21.
    Hofmann C, Burg G, Jung C (1986) Kutane Nebenwirkungen der Goldtherapie. Klinische und histologische Ergebnisse. Z Rheum 45:100–106Google Scholar
  22. 22.
    Hertl M, Jugert F, Merk HF (1995) CD8+ dermal T cells from a sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes. Br J Dermatol 132: 215–220PubMedGoogle Scholar
  23. 23.
    Hurwitz M, Rivera HP, Gooch MH, Slama TG, Handt A, Weiss J (1982) Toxic shock syndrome or toxic epidermal necrolysis? J Am Acad Dermatol 7:246–254PubMedCrossRefGoogle Scholar
  24. 24.
    Kaplan AP (1984) Drug induced skin disease. J Allergy Clin Immunol 74:573–579PubMedCrossRefGoogle Scholar
  25. 25.
    Kasemir H, Kerp L (1980) Arzneimittel-Allergene und Arzneimittel-Allergien. In: Filipp G (ed) Allergologie, vol 1. Ätiopathogenese. Werk-Verlag, Gräfelfing, p 144Google Scholar
  26. 26.
    Kauppinen K, Stubb S (1984) Drug eruptions: Causative agents and clinical types. A series of inpatients during a 10-year period. Acta Derm Venereol (Stockh) 64:320–324PubMedGoogle Scholar
  27. 27.
    Kazmierowski JA, Wuepper KD (1981) Erythema multiforme: Clinical spectrum and immunopathogenesis. Springer Semin Immunopathol 4:45PubMedCrossRefGoogle Scholar
  28. 28.
    Kleinhans D, Fuchs T (1984) Orale Provokation bei einem durch Barbitursäure verursachten Lyell-Syndrom. Akt Derm 10:122–124Google Scholar
  29. 29.
    Knowles SR, Uetrecht J, Shear NH (2000) Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet 356:1587–1591PubMedCrossRefGoogle Scholar
  30. 30.
    Konstantinow A, Mühlbauer W, Balda BR, Ring J (2001) Toxische epidermale Nekrolysen (Arzneimittel-induziertes Lyell-Syndrom). Dtsch Med Wochenschr 126:141–144, 177–179PubMedCrossRefGoogle Scholar
  31. 31.
    Le Cleach L, Delaire S, Boumsell L, et al (2000) Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol 119:225–230PubMedCrossRefGoogle Scholar
  32. 32.
    Luderschmidt C, Linderkamp O, Ring J (1985) Drug-induced toxic epidermal necrolysis (Lyell’s syndrome) in a 4-year-old girl. Eur J Pediatr 14:91–93CrossRefGoogle Scholar
  33. 33.
    Lyell A (1956) Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 68:355–361PubMedCrossRefGoogle Scholar
  34. 34.
    Lyell A (1967) A review of toxic epidermal necrolysis in Britain. Br J Derm 79:662–671CrossRefGoogle Scholar
  35. 35.
    Marghescu S (1978) Allergische Arznei-Exantheme. Pathomechanismus — Klinik — Testung — Therapie. Perimed, ErlangenGoogle Scholar
  36. 36.
    Merk H, Gerecke D (1986) Arzneimittelnebenwirkungen bei Patienten mit LAV/HTLV-III-Infektion. AIDS-Bericht 2. Grosse, Berlin, pp 139–142Google Scholar
  37. 37.
    Merk HF, Hertl M (1996) Immunologic mechanisms of cutaneous drug reactions. Semin Cutan MedSurg 15:228–235CrossRefGoogle Scholar
  38. 38.
    Merot Y, Saurat JH (1985) Clues to pathogenesis of toxic epidermal necrolysis. Int J Dermatol 24:165–168PubMedGoogle Scholar
  39. 39.
    Mockenhaupt M, Norgauer J (2001) Schwere arzneimittelinduzierte Hautreaktionen. Allergologie 24:419–432Google Scholar
  40. 40.
    Mougdil A, Porat S, Brunnel P, Jordan SC (1995) Treatment of Stevens-Johnson syndrome with pooled human intravenous immune globulin. Clin Pediatrics 34:47–51Google Scholar
  41. 41.
    Murphy GF, Guillén FJ, Flynn TC (1985) Cytotoxic T lymphocytes and phenotypically abnormal epidermal dendritic cells in fixed cutaneous eruptions. Hum Pathol 16:1264–1271PubMedCrossRefGoogle Scholar
  42. 42.
    Pichler WJ, Yawalkar N (2000) Allergic reactions to drugs: involvement of T cells. Thorax 55[Suppl 2]:S61–S65PubMedCrossRefGoogle Scholar
  43. 43.
    Pichler WJ, Zanni M, von Greyerz S, et al. (1997) High IL-5 production by human drug-specific T cell clones. Int Arch Allergy Immunol 113: 177–180PubMedCrossRefGoogle Scholar
  44. 44.
    Ring J (1987) Diagnostik von Arzneimittel-bedingten Unverträglichkeitsreaktionen. Hautarzt 38:16–22Google Scholar
  45. 45.
    Ring J (1989) Drug-induced Leyell’s syndrome (toxic epidermal necrolysis). In: Pichler WJ, et al. (eds) Progress in allergy and clinical immunology. Hogrefe & Huber, Toronto, pp 455–461Google Scholar
  46. 46.
    Ring J, Przybilla B, Gollhausen R (1989) Progressive pigmentary purpura provoked by a phytotherapeutic drug containing Echinacea extract. Allergy Clin Immunol News 114:108–109Google Scholar
  47. 47.
    Ring J, Kraus K, Fröschl M, Brunner R, Przybilla B, Burg G, Braun-Falco O (1987) AIDS, HIV-Infektion und allergische Reaktionen. AIDS Forschung 2:643–646Google Scholar
  48. 48.
    Roujeau JC, Kelly JP, Naldi L, et al. (1995) Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333:1600–1607PubMedCrossRefGoogle Scholar
  49. 49.
    Roujeau J-C, Stern RS (1994) Severe cutaneous adverse reactions to drugs. N Engl J Med 331: 1272–1285PubMedCrossRefGoogle Scholar
  50. 50.
    Ruiz-Maldonado R (1985) Acute disseminated epidermal necrosis types 1,2, and 3: Study of sixty cases. J Am Acad Dermatol 13:623–635PubMedCrossRefGoogle Scholar
  51. 51.
    Rzany B, Hering O, Mockenhaupt M, et al. (1996) Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 135:6–11PubMedCrossRefGoogle Scholar
  52. 52.
    Sachs B, Merk H (2001) Demonstration and characterization of drug-specific lymphocyte reactivity in drug allergies. Allergy Clin Immunol Int 13:91–98CrossRefGoogle Scholar
  53. 53.
    Schöpf E, Stühmer A, Rzany B, Victor N, Zentgraf R, Kapp JF (1991) Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 127:839–842PubMedCrossRefGoogle Scholar
  54. 54.
    Schulz KH (1966) Stellenwert und Aussagekraft von Testmethoden bei allergischen Arznei-Exanthemen. In: Braun-Falco O, Wolff HH (1979) Fortschritte der praktischen Dermatologie und Venerologie, vol 9. Springer, Berlin Heidelberg New York, p 71Google Scholar
  55. 55.
    Steigleder GK (1966) Haut. In: Heintz R (ed) Erkrankungen durch Arzneimittel. Diagnostik, Klinik, Pathogenese und Therapie. Thieme, Stuttgart, pp 103–130Google Scholar
  56. 56.
    Schulz JT, Sheridan RL, Ryan CM, et al. (2000) A 10-year experience with toxic epidermal necrolysis. J Burn Care Rehabil 21:199–204PubMedCrossRefGoogle Scholar
  57. 57.
    Smith CL, Brown I, Torraca BM (1997) Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus. Clin Infect Dis 25:1477–1478PubMedCrossRefGoogle Scholar
  58. 58.
    Todd J, Fishaut M, Kapral F, Welch T (1978) Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet II:1116–1118CrossRefGoogle Scholar
  59. 59.
    Viard I, Wehrli P, Bullani R, et al. (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282:490–493PubMedCrossRefGoogle Scholar
  60. 60.
    Stern RS, Wintroub BU (1999) Cutaneous reactions to drugs. In: Freedberg IM, Eisen AZ, Wolff K, et al. (eds) Fitzpatrick’s dermatology in general medicine, 5th edn. McGraw Hill, New York, pp 1633–1642Google Scholar
  61. 61.
    Wolff HH, Winzer M (1986) Histopathological patterns of drug eruptions. In: Ring J, Burg G (eds) New trends in allergy II. Springer, Berlin Heidelberg New York, pp 240–253Google Scholar
  62. 62.
    Zürcher K, Krebs A (1992) Cutaneous drug reactions. Karger, BaselGoogle Scholar

References

  1. 1.
    Apostolou I, Takahama Y, Belmant C, Kawanos T, Huerre M, Marchal G, Cui J, Taniguchi M, Nakauchi H, Fournie J-J, Kourilsky P, Gachelin G (1999) Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci USA 96:5141–5146PubMedCrossRefGoogle Scholar
  2. 2.
    Baumgarten C (1978) Häufigste Nebenwirkungen bei der spezifischen Hyposensibilisierung. Allergologie 1:223–228Google Scholar
  3. 3.
    Bode U, Ring J, Schmoeckel Chr (1984) Granulom-bildung nach intrakutaner Applikation von Procain-Polyvinylpyrrolidon (PVP). Hautarzt 35:474–477PubMedGoogle Scholar
  4. 4.
    Bork K, Hoede N (1982) Vortäuschung maligner Tumoren durch nicht deklariertes PVP in Arzneimitteln. Hautarzt 33:373–377PubMedGoogle Scholar
  5. 5.
    Boros DL (1981) The role of lymphokines in granulomatous inflammations. Lymphokines 3:257–281Google Scholar
  6. 6.
    Braun-Falco O, Plewig G, Wolff HH (1998) Derma tologie und Venerologie, 4th edn. Springer, Berlin Heidelberg New YorkGoogle Scholar
  7. 7.
    Castrow FFII, Krull E (1983) An injectable collagen implant — update. J Am Acad Dermatol 9: 889–893PubMedCrossRefGoogle Scholar
  8. 28.
    Cooperman LS, Mackinnon V, Bechler G, Pharriss BB (1983) Injectable collagen: A six-year clinical investigation. Aesth Plast Surg 9:145–151CrossRefGoogle Scholar
  9. 9.
    Dahl M, Ullmann S, Goetz RW (1977) Vasculitis in granuloma anulare. Arch Dermatol 113:463–467PubMedCrossRefGoogle Scholar
  10. 10.
    Eberlein-König B, Hein R, Abeck D, Engst R, Ring J (1999) Cutaneous sarcoid foreign body granulomas developing in sites of previous skin injury after systemic interferon-alpha treatment for chronic hepatitis C. Br J Dermatol 140:370–372PubMedCrossRefGoogle Scholar
  11. 11.
    Eder M, Gedigk P (1986) Lehrbuch der allgemeinen Pathologie und pathologischen Anatomie. Springer, Berlin Heidelberg New YorkGoogle Scholar
  12. 12.
    Ellingsworth LR, DeLustro F, Brennan JE, Sawamura S, McPherson J (1986) The human immune response to reconstituted bovine collagen. J Immunol 36:877–882Google Scholar
  13. 13.
    Harms M, Masouyé I, Saurat JH (1990) Silica granuloma mimicking granulomatous cheilitis. Dermatologica 181:246–247PubMedCrossRefGoogle Scholar
  14. 14.
    Kleinhans D, Knoth W (1977) Immunhistochemischer Fibrin-Nachweis beim Granuloma anulare. Arch Dermatol Res 258:231–234PubMedCrossRefGoogle Scholar
  15. 15.
    Klepzig K, Ring J, Burg G (1987) Pseudolymphom nach Hyposensibilisierung. Allergologie 10:432Google Scholar
  16. 16.
    Kligman AM, Armstrong RC (1986) Histologic response to intradermal zyderm und zyplast (glutaraldehyde crosslinked) collagen in humans. J Dermatol Surg Oncol 12:351–357PubMedGoogle Scholar
  17. 17.
    Konz B (1983) Injizierbares Kollagen. In: Braun-Falco O, Burg G (eds) Fortschritte der praktischen Dermatologie und Venerologie, vol. 10, pp 193–198. Springer, Berlin Heidelberg New YorkGoogle Scholar
  18. 18.
    Kuhn K, Timpl R (1984) Collagens. Molecular and antigenic structure. In: Myelofibrosis and the biology of connective tissue, p. 45. Liss, New YorkGoogle Scholar
  19. 19.
    Lombardi T, Kuffer R, Dubrez B (2001) Polishing-paste-induced silica granuloma of the gingiva. Dermatology 203:177–179PubMedCrossRefGoogle Scholar
  20. 20.
    McCoy JP, Schade WJ, Siegle RJ, Vanderveen EE, Zachary CB, Waldinger TP, Swanson NY (1987) Immune responses to bovine collagen implants. J Am Acad Dermatol 16:955–960PubMedCrossRefGoogle Scholar
  21. 22.
    Rapaport M (1984) Granuloma annulare caused by injectable collagen. Arch Dermatol 120:837PubMedCrossRefGoogle Scholar
  22. 23.
    Raupach B, Kaufman S (2001) Immune responses to intracellular bacteria. Curr Opin Immunol 13:417–428PubMedCrossRefGoogle Scholar
  23. 24.
    Roach DR, Briscoe H, Saunders B, France MP, Riminton S, Britton WJ (2001) Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J Exp Med 193: 239–246PubMedCrossRefGoogle Scholar
  24. 25.
    Roitt I, Delves P (2001) Essential immunology, 10th edn. Blackwell, OxfordGoogle Scholar
  25. 26.
    Sandritter W, Beneke G (1984) Allgemeine Pathologie. Schattauer, StuttgartGoogle Scholar
  26. 27.
    Sellem PH, Caranzan FR, Bene MC, Faure GC (1987) Immunogenicity of injectable collagen implants. J Dermatol Surg Oncol 13:1199–1202PubMedGoogle Scholar
  27. 28.
    Shelley WB, Hurley HJ (1960) The pathogenesis of silica granulomas in man: A nonallergic colloidal phenomenon. J Invest Dermatol 34:107–123PubMedGoogle Scholar
  28. 29.
    Schurig V, Konz B, Ring J, Dorn M (1986) Granulombildung an Test-und Behandlungsstellen durch intrakutan verabreichtes, injizierbares Kollagen. Hautarzt 37:42–45PubMedGoogle Scholar
  29. 30.
    Shelley WB, Hurrley HJ (1958) The allergic origin of zirconium deodorant granulomas. Br J Dermatol 70:75–82PubMedCrossRefGoogle Scholar

References

  1. 1.
    Almon RR, Andrew CG, Appel SH (1974) Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science 186:55–57PubMedCrossRefGoogle Scholar
  2. 2.
    Atkinson MA, Maclaren NK (1994) The pathogenesis of insulin-dependent diabetes mellitus. N Engl JMed 331:1428–1436CrossRefGoogle Scholar
  3. 3.
    Beck K, Hertel J, Rasmussen NG, et al. (1991) Effect of maternal thyroid antibodies and postpartum thyroiditis on the fetus and neonate. Acta Endocrinol 125:146:149Google Scholar
  4. 4.
    Chapel H, Haeney M (1993) Essentials of clinical immunology, 3rd edn. Blackwell, OxfordGoogle Scholar
  5. 5.
    Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW (1993) Autoantibodies against high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 328:1599–1604PubMedCrossRefGoogle Scholar
  6. 6.
    King C, Sarvetnick N (1997) Organ-specific auto-immunity. Curr Opin Immunol 9:863–871PubMedCrossRefGoogle Scholar
  7. 7.
    Peter HH, Pichler WJ (1996) Klinische Immuno-logie, 2nd edn. Urban & Schwarzenberg, MunichGoogle Scholar
  8. 8.
    Roitt IM (1996) Essential immunology, 8th edn. Blackwell, OxfordGoogle Scholar
  9. 9.
    Shoenfeld Y, Isenberg D (eds) (1993) Natural autoantibodies. CRC Press, Boca Raton, FloridaGoogle Scholar
  10. 10.
    Stadler BM, Miescher S, Horn M, et al. (2001) Allergic manifestations as the results of a conditional autoimmune response. Int Arch Allergy Immunol 124:411–413PubMedCrossRefGoogle Scholar
  11. 11.
    Tan EM (1982) Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol 33:167–240PubMedCrossRefGoogle Scholar
  12. 12.
    Valenta R, Seiberler S, Natter S, et al. (2000) Auto-allergy: a pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol 105:432–437PubMedCrossRefGoogle Scholar
  13. 13.
    Venter JC, Fraser CM (1981) The development of monoclonal antibodies to beta-adrenergic receptors and their use in receptor purification and characterization. In: Eisenbarth G, Fellows R (eds) Monoclonal antibodies in endocrine research. Raven Press, New York, pp 119–134Google Scholar
  14. 14.
    Vincent A, Mewsom-Davis J (1982) Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles. Clin Exp Immunol 49:257–265PubMedGoogle Scholar
  15. 15.
    Wegmann DR (1996) The immune response to islets in experimental diabetes and insulin-dependent diabetes mellitus. Curr Opin Immunol 8:860–864PubMedCrossRefGoogle Scholar

References

  1. 1.
    Abbey SE, Garfinkel PE (1991) Neurasthenia and chronic fatigue syndrome: The role of culture in making of a diagnosis. Am J Psychiatry 148: 1638–11646PubMedGoogle Scholar
  2. 2.
    Altenkirch H (1995) Multiple chemical sensitivity (MCS)-Syndrom. Gesundheitswesen 57:661–666PubMedGoogle Scholar
  3. 3.
    Bartenstein PF, Grundwald F, Herholz K, Kuwert T, Tatsch K, Sabri O, Weiller C (1999) Rolle der Positronen-Emissions-Tomographie (PET) und Single-Photon-Emissions-Tomographie (SPECT) bei der sogenannten “Multiple Chemical Sensitivity” (MCS). Nuklearmedizin 38:297–301PubMedGoogle Scholar
  4. 4.
    Bell IR, Miller CS, Schwarz GE, et al. (1996) Neu-ropsychiatric and somatic characteristics of young adults with and without self-reported chemical odor intolerance and chemical sensitivity. Arch Environ Health 51:9–21PubMedCrossRefGoogle Scholar
  5. 5.
    Binkley K, King N, Poonai N, Seeman P, Ulpian C, Kennedy J (2001) Idiopathic environmental intolerance: Increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7. J Allergy Clin Immunol 107:887–890PubMedCrossRefGoogle Scholar
  6. 6.
    Bornschein S, Hausteiner C, Zilker Th, Bickel H, Förstl H (2000) Psychiatrische und somatische Morbidität bei Patienten mit vermuteter Multiple Chemical Sensitivity (MCS). Nervenarzt 71: 737–744PubMedCrossRefGoogle Scholar
  7. 7.
    Bullinger M (1989) Psychological effects of air pollution on healthy residents — a time-series approach. J Environ Psychol 9:103–118CrossRefGoogle Scholar
  8. 8.
    Cullen MR (1987) The worker with multiple chemical sensitivities: An overview. State Art Rev Occup Med 2:655–661Google Scholar
  9. 9.
    Derbolowsky J (1999) Die Glaubwürdigkeit wieder herstellen. Zeitschr Umweltmed 7:2–4Google Scholar
  10. 10.
    Eberlein-König B, Przybilla B, Kühnl P, Pechak J, Gebefügi I, Kleinschmidt J, Ring J (1998) Influence of airborne nitrogen dioxide or formaldehyde on parameters of skin function and cellular activation in patients with atopic eczema and control subjects. J Allergy Clin Immunol 101: 141–143PubMedCrossRefGoogle Scholar
  11. 11.
    Eikmann T, Herr C (2001) Ein Paradigmenwechsel in der Umweltmedizin? Umwelt Forschung Prax 6:179–180Google Scholar
  12. 12.
    Fabig K-R (1999) Glutathion-S-Transferase T1 und Multiple Chemikaliensensitivität (MCS). Umwelt Medizin Gesellschaft 12:226–232Google Scholar
  13. 13.
    Gieler U, et al. (1998) Therapeutische Aspekte des MCS-Syndroms. Umweltmed Forschung Praxis 3:3–10Google Scholar
  14. 14.
    Grimm V, Ruhdorfer S, Eberlein-König B, Scherer G, Engst R, Ring J (1999) Defizit der Glutathi-ontransferase bei Patienten mit Öko-Syndrom? Allergo J 8[Suppl 1]:32Google Scholar
  15. 15.
    Hüppe M, Bullinger M ((1997) Verfahren zur MCS-Diagnostik. Zusammenfassung und Bewertung einer Umfrage. Umweltmed Forschung Prax 2:291–294Google Scholar
  16. 16.
    IPCS (International Programme on Chemical Safety) (1996) Report of Multiple Chemical Sensitivities (MCS) Workshop. Berlin, Inst Arch Occup Environ Health 69:224–226Google Scholar
  17. 17.
    Kofler W (1993) Umweltängste, Toxikopie-Mechanismus, komplexes evolutionäres Coping-Modell und die Notwendigkeit neuartiger Auflagen für genehmigungspflichtige Anlagen. In: Aurand K, Hazard BP, Tretter F (eds) Umweltbelastungen und Ängste. Westdeutscher Verlag, Wiesbaden, pp 225–226Google Scholar
  18. 18.
    Kröling P (1989) Zur Problematik des “Sick building”-Syndroms. Allergologie 3:118–129Google Scholar
  19. 19.
    Molina C, Caillaud D, Molina N (1993) Sick building syndrome and atopy. Indoor Air 1:369–373Google Scholar
  20. 20.
    Neuhann HF, Wiesmüller GA (1994) Diagnostische Strategien bei gebäudebezogenen Gesundheitsstörungen. In: Luftverunreinigung in Innenräumen. VDI Berichte 1122Google Scholar
  21. 21.
    Nixon PGF (1982) “Total allergy syndrome” or fluctuating hypercarbia? Lancet I:516Google Scholar
  22. 22.
    Österberg OP, Akesson B, Bergendorf U, Karlson B, Seger L (1998) Suprathreshold intensity and annoyance reactions in experimental challenge to toluene and n-butyl acetate among subjects with long-term solvent exposure. Scand J Work Environ Health 24:432–438PubMedGoogle Scholar
  23. 23.
    Ring J, Gabriel G, Vieluf D, Przybilla B (1991) “Das klinische Ökologie-Syndrom” (“Öko-Syndrom”): Polysomatische Beschwerden bei vermuteter Allergie gegen Umweltschadstoffe. Münch Med Wochenschr 133:50–55Google Scholar
  24. 24.
    Ring J, Eberlein-König B, Behrendt H (1999) “Eco-Syndrome” (“multiple chemical sensitivity”-MCS). Zbl Hyg Umweltmed 202:207–218Google Scholar
  25. 25.
    Ring J, Triendl C, Behrendt H, Borelli S (2000) Das Öko-Syndrom (multiple chemical sensitivity) und verwandte Syndrome. In: Przybilla B, Bergmann KCh, Ring J (eds) Praktische allergologische Diagnostik. Steinkopff, Darmstadt, pp 351–371Google Scholar
  26. 26.
    Röttgers HR (2000) Psychisch Kranke in der Umweltmedizin. Deutsches Ärzteblatt 97:A835–A840Google Scholar
  27. 27.
    Selner JC, Staudemayer H (1992) Neuropsycho-physiologic observation in patients presenting with environmental illness. Toxicol Indust Health 8:145–155Google Scholar
  28. 28.
    Staudenmayer H, Selner J, Buhr M (1993) Double-blind provocation chamber challenges in 20 patients presenting with “multiple chemical sensitivity”. Regul Toxicol Pharmacol 18:44–53PubMedCrossRefGoogle Scholar
  29. 29.
    Staudenmayer H, Selner M, Selner J (1993) Adult sequelae of childhood abuse presenting as environmental illness. Ann Allergy 71:538–546PubMedGoogle Scholar
  30. 30.
    Terr A (1993) Immunological issues in “multiple chemical sensitivities”. Regul Toxicol Pharmacol 18:54–60PubMedCrossRefGoogle Scholar
  31. 31.
    Tretter F (1996) Umweltbezogene funktionelle Syndrome. Int Praxis 37:669–686Google Scholar
  32. 32.
    Triendl C, Borelli S, Rakoski J, Herschbach P, Behrendt H, Ring J (1999) Das “Öko-Syndrom” (multiple chemical sensitivity”): Allergologisch-umweltmedizinisches Management. Allergologie 22: 744–760Google Scholar
  33. 33.
    Voack C, Borelli S, Ring J (1997) Der umweltme-dizinische 4-Stufenplan. Münch Med Wochenschr 139:69–72Google Scholar
  34. 34.
    Wiesmüller GA, Hornberg D ((2001) Multiple Chemikalienüberempfindlichkeiten (MCS). Eine Herausforderung moderner Diagnostik und Therapie. Allergologie 24:507–51Google Scholar
  35. 35.
    Zilker M (1991) Pathophysiological mechanisms of fibromyalgia. Clin J Pain 7[Suppl 1]:8–15Google Scholar
  36. 36.
    Wüthrich B ((2001) Allergien: Umweltkrankheiten Nummer 1. Der Allergie-Patient im Span-nungsfeld zwischen Schul-und Alternativmedizin. Dermatol Beruf Umwelt/Occup Environ Der-matol 49:136 141Google Scholar
  37. 37.
    Walkowiak J, Wiener J-A, Fastabend A, Heinzow B, Krämer U, Schmidt E, Steingrüber H-J, Wundram S, Winneke G ((2001) Environmental exposure to polychlorinated biphenyls and quality of the home environment: effect on psychodevelopment in early childhood. Lancet 358:1602–1607PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Personalised recommendations